Johan de Fijter
Gast hoogleraar
- Naam
- Prof.dr. J.W. de Fijter
- j.w.de_fijter@lumc.nl
Professor de Fijter is hoogleraar Nierziekten, in het bijzonder Niertransplantatie. Hij is internist-nefroloog, hoofdopleider interne geneeskunde (LUMC/ Regio Leiden) en lid van het Regionaal Tuchtcollege voor de Gezondheidszorg (Den Haag).
Professor de Fijter is hoogleraar Nierziekten, in het bijzonder Niertransplantatie. Hij is internist-nefroloog, hoofdopleider interne geneeskunde (LUMC/ Regio Leiden) en lid van het Regionaal Tuchtcollege voor de Gezondheidszorg (Den Haag).
Wetenschappelijke carrière
PhD Thesis: The mucosal immune response in primary IgA nephropathy. (13 mei 1998)
Oratie: Transplantatie “vertalen” in toekomst (8 september 2006)
Hoogleraar Nierziekte, in het bijzonder niertransplantatie
- Faculteit Geneeskunde
- Divisie 2
- Interne Geneeskunde
- Nierziekten
Gast hoogleraar
- Faculteit Geneeskunde
- Divisie 2
- Interne Geneeskunde
- Nierziekten
- Born, J.C. van den; Meziyerh, S.; Vart, P.; Bakker, S.J.L.; Berger, S.P.; Florquin, S.; Fijter, J.W. de; Gomes-Neto, A.W.; Idu, M.M.; Pol, R.A.; Roelen, D.L.; Sandwijk, M.S. van; Vries, D.K. de; Vries, A.P.J. de; Bemelman, F.J. & Sanders, J.S.F. (2024), Comparison of 2 immunosuppression minimization strategies in kidney transplantation, Transplantation 108(2): 556-566.
- Kardol-Hoefnagel, T.; Senejohnny, D.M.; Kamburova, E.G.; Wisse, B.W.; Reteig, L.; Gruijters, M.L.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F.E. van; Zuilen, A.D. van; Verhaar, M.C.; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Melchers, R.C.A.; Seelen, M.A.J.; Sanders, J.S.; Hepkema, B.G.; Lambeck, A.J.A.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.A.C.J.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, S.A.; Lardy, N.M.; Swelsen, W.; Pant, K.A.M.I. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Hoitsma, A.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Roelen, D.L.; Claas, F.H.; Bemelman, F.J.; Senev, A.; Naesens, M.; Heidt, S. & Otten, H.G. (2024), Determination of the clinical relevance of donor epitope-specific HLA-antibodies in kidney transplantation, HLA: Immune Response Genetics 103(1).
- Kardol-Hoefnagel, T.; Senejohnny, D.M.; Kamburova, E.G.; Wisse, B.W.; Gruijters, M.L.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F.E. van; Zuilen, A.D. van; Verhaar, M.C.; Drop, A.C.A.D.; Plaisier, L.; Melchers, R.C.A.; Seelen, M.A.J.; Sanders, J.S.; Hepkema, B.G.; Kroesen, B.J.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.A.C.J.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, S.A.; Lardy, N.M.; Swelsen, W.; Pant, K.A.M.I. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Hoitsma, A.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Roelen, D.L.; Claas, F.H.; Bemelman, F.J.; Heidt, S. & Otten, H.G. (2024), Ellipro scores of donor epitope specific HLA antibodies are not associated with kidney graft survival, HLA: Immune Response Genetics 103(1).
- Lengton, R.; Dekker, F.W.; Rossum, E.F.C. van; Fijter, J.W. de; Rosendaal, F.R.; Dijk, K.W. van; Rabelink, T.J.; Cessie, S. le; Mutsert, R. de & Hoogeveen, E.K. (2024), Hypertension and diabetes, but not leptin and adiponectin, mediate the relationship between body fat and chronic kidney disease, Endocrine 85(3): 1141-1153.
- Bredewold, O.W.; Moest, W.T.; Fijter, J.W. de; Meijers, E.; Bruchfeld, A.; Skov, K.; Svensson, M.H.S.; Chan, J.; Mjornstedt, L.; Sorensen, S.S.; Fellstrom, B.; Feltkamp, M.C.W.; Zonneveld, A.J. van & Rotmans, J.I. (2024), Attenuation of Torque teno viral load over time in kidney transplantation recipients treated with calcineurin inhibitors is mitigated after conversion to belatacept, Journal of Medical Virology 96(9).
- Duijl, T.T. van; Rooij, E.N.M. de; Treep, M.M.; Koelemaij, M.E.; Romijn, F.P.H.T.M.; Hoogeveen, E.K.; Ruhaak, L.R.; Cessie, S. le; Fijter, J.W. de & Cobbaert, C.M. (2023), Urinary kidney injury biomarkers are associated with ischemia-reperfusion injury severity in kidney allograft recipients, Clinical Chemistry 69(8).
- Fijter, J. de; Dreyer, G.; Mallat, M.; Budde, K.; Pratschke, J.; Klempnauer, J.; Zeier, M.; Arns, W.; Hugo, C.; Rump, L.C.; Hauser, I.; Schenker, P.; Schiffer, M.; Grimm, M.O.; Kliem, V.; Olbricht, C.J.; Pisarski, P.; Banas, B.; Suwelack, B.; Hakenberg, O.; Berlakovich, G.; Schneeberger, S.; Wetering, J. van de; Berger, S.; Bemelman, F.; Kuypers, D.; Heidt, S.; Rahmel, A.; Claas, F.; Peeters, P.; Oberbauer, R.; Heemann, U.; Krämer, B.K. & Eurotransplant Senior (2023), A paired-kidney allocation study found superior survival with HLA-DR compatible kidney transplants in the Eurotransplant Senior Program, Kidney International 104(3): 552-561.
- Bredewold, O.W.; Chan, J.; Svensson, M.; Bruchfeld, A.; Fijter, J.W. de; Furuland, H.; Grinyo, J.M.; Hartmann, A.; Holdaas, H.; Hellberg, O.; Jardine, A.; Mjornstedt, L.; Skov, K.; Smerud, K.T.; Soveri, I.; Sorensen, S.S.; Zonneveld, A.J. van & Fellstrom, B. (2023), Cardiovascular risk following conversion to belatacept from a calcineurin inhibitor in kidney transplant recipients, KIDNEY MEDICINE 5(1).
- Zhai, Q.; Moes, D.; Gelder, T. van; Lee, M. van der; Heide, J.H. van der; Sanders, J.; Bemelman, F.; Fijter, J. de & Swen, J. (2023), EFFECT OF GENETIC VARIANTS IN TSPYL ON THE PHARMACOKINETICS OF CYCLOSPORINE, Clinical Pharmacology & Therapeutics 113: S23-S23.
- Meziyerh, S.; Bouwmans, P.; Gelder, T. van; Helm, D. van der; Messchendorp, L.; Boog, P.J.M. van der; Fijter, J.W. de; Moes, D.J.A.R.; Vries, A.P.J. de & RECOVAC Collaborators (2023), Mycophenolic acid exposure determines antibody formation following SARS-CoV-2 vaccination in kidney transplant recipients, Clinical Pharmacology & Therapeutics.
- Westgeest, A.C.; Schippers, E.F.; Delfos, N.M.; Visser, L.G.; Fijter, J.W. de; Boer, M.G.J. de & Lambregts, M.M.C. (2022), Acute kidney injury in Staphylococcus aureus bacteremia, European Journal of Clinical Microbiology and Infectious Diseases 41.
- Duijl, T.T. van; Ruhaak, L.R.; Kooten, C. van; Fijter, J.W. de & Cobbaert, C.M. (2022), Multiplex LC-MS/MS testing for early detection of kidney injury, JOURNAL OF APPLIED LABORATORY MEDICINE 7(4): 923-930.
- Bezstarosti, S.; Bakker, K.H.; Kramer, C.S.M.; Fijter, J.W. de; Reinders, M.E.J.; Mulder, A.; Claas, F.H.J. & Heidt, S. (2022), A comprehensive evaluation of the antibody-verified status of eplets listed in the HLA epitope registry, HLA: Immune Response Genetics 99(5): 420-421.
- Bezstarosti, S.; Bakker, K.H.; Kramer, C.S.M.; Fijter, J.W. de; Reinders, M.E.J.; Mulder, A.; Claas, F.H.J. & Heidt, S. (2022), A comprehensive evaluation of the antibody-verified status of eplets listed in the HLA Epitope Registry, Frontiers in Immunology 12.
- Dekker, S.E.I.; Verhoeven, A.; Frey, D.; Soonawala, D.; Peters, D.J.M.; Mayboroda, O.A. & Fijter, J.W. de (2022), Change in urinary myoinositol/citrate ratio associates with progressive loss of renal function in ADPKD patients, American Journal of Nephrology 53(6): 470-480.
- Meziyerh, S.; Tomer, A.; Peters-Sengers, H.; Helm, D. van der; Coemans, M.; Pieters, T.; Venhuizen, J.H.; Haitjema, S.; Moes, D.J.; Michels, W.; Fijter, H. de; Boog, P. van der; Nguyen, T.; Florquin, S.; Zuilen, A. van; Bemelman, F.; Nurmohamed, A.; Steyerberg, E.; Rizopoulos, D.; Naesens, M.; Vries, A. de & Kers, J. (2022), Development of High-Performing and Multicenter-Validated Dynamic Prediction Models With Longitudinal Measurements of Serum Creatinine and Proteinuria for Death-Censored Kidney Graft Failure, Transplantation 106(9): S376-S376.
- Meziyerh, S.; Rijn, A.L. van; Helm, D. van der; Gelder, T. van; Boog, P.J.M. van der; Kroes, A.C.M.; Fijter, J.W. de; Moes, D.J.A.R.; Rotmans, J.I.; Feltkamp, M.C. & Vries, A.P.J. de (2022), Early Tacrolimus Exposure Is Associated With BK-Viremia in Kidney Transplant Recipients, Transplantation 106(9): S199-S199.
- Meziyerh, S.; Rijn, A.L. van; Helm, D. van der; Boog, P.J. van der; Gelder, T. van; Kroes, A.C.; Fijter, J.W. de; Moes, D.J.; Rotmans, J.I.; Feltkamp, M.C. & Vries, A.P. de (2022), Early Tacrolimus Exposure is Associated with BK-Viremia in Kidney Transplant Recipients., American Journal of Transplantation 22: 447-447.
- Bezstarosti, S.; Zwart, T.C.; Achini, F.R.; Schilham, M.W.; Moes, D.J.A.R.; Reinders, M.E.J.; Fijter, J.W. de & Heidt, S. (2022), High Alemtuzumab Exposure Is Associated With Delayed Lymphocyte Recovery in Kidney Transplant Recipients, Transplantation 106(9): S166-S166.
- Bezstarosti, S.; Bakker, K.H.; Roelen, D.L.; Heidt, S.; Reinders, M.E.; Meziyerh, S.; Fijter, J.W. de & Meziyerh, S. (2022), HLA-DQ EPLET MISMATCH LOAD IDENTIFIES KIDNEY TRANSPLANT PATIENTS ELIGIBLE FOR TACROLIMUS WITHDRAWAL WITHOUT DONOR-SPECIFIC ANTIBODY FORMATION, Human Immunology 83: 21-21.
- Bezstarosti, S.; Kramer, C.S.M.; Franke-van Dijk, M.E.I.; Vergunst, M.; Bakker, K.H.; Uyar-Mercankaya, M.; Buchli, R.; Roelen, D.L.; Fijter, J.W. de; Claas, F.H.J. & Heidt, S. (2022), HLA-DQ-specific recombinant human monoclonal antibodies allow for in-depth analysis of HLA-DQ epitopes, Frontiers in Immunology 12.
- Bezstarosti, S.; Kramer, C.S.M.; Claas, F.H.J.; Fijter, J.W. de; Reinders, M.E.J. & Heidt, S. (2022), Implementation of molecular matching in transplantation requires further characterization of both immunogenicity and antigenicity of individual HLA epitopes, Human Immunology 83(3): 256-263.
- Duijl, T.T. van; Ruhaak, L.R.; Kooten, C. van; Fijter, J.W. de & Cobbaert, C.M. (2022), Multiplex LC-MS/MS testing for early detection of kidney injury, JOURNAL OF APPLIED LABORATORY MEDICINE 7(4): 923-930.
- Zwart, T.C.; Bezstarosti, S.; Achini, F.R.; Reinders, M.E.J.; Schilham, M.W.; Heidt, S.; Guchelaar, H.J.; Fijter, J.W. de & Moes, D.J.A.R. (2022), Population pharmacokinetics of subcutaneous alemtuzumab in kidney transplantation, British Journal of Clinical Pharmacology 89(4).
- Alem, C.M.A. van; Bank, J.R.; Vries, D.K. de; Bajema, I.M.; Mallat, M.J.K.; Fijter, J.W. de; Rotmans, J.I. & Kooten, C. van (2022), Presence of CD163+macrophages in DCD kidneys with high DGF reduces the risk for acute cellular rejection in 6 months after kidney transplantation, Transplant Immunology 75.
- Rooij, E.N.M. de; Meuleman, Y.; Fijter, J.W. de; Cessie, S. le; Jager, K.J.; Chesnaye, N.C.; Evans, M.; Pagels, A.A.; Caskey, F.J.; Torino, C.; Porto, G.; Szymczak, M.; Drechsler, C.; Wanner, C.; Dekker, F.W.; Hoogeveen, E.K. & EQUAL Study Investigators (2022), Quality of life before and after the start of dialysis in older patients, Clinical Journal of the American Society of Nephrology 17(8): 1159-1167.
- Meziyerh, S.; Gelder, T. van; Helm, D. van der; Boog, P.J.M. van der; Fijter, J.W. de; Moes, D.J.A.R. & Vries, A.P.J. de (2022), Real-Life Tacrolimus Levels Are Associated With Biopsyproven Acute Rejection After the First Year Post-kidney Transplantation, Transplantation 106(9): S198-S198.
- Meziyerh, S.; Gelder, T. van; Helm, D. van der; Boog, P.J. van der; Fijter, J.W. de; Moes, D.J. & Vries, A.P. de (2022), Real-Life Tacrolimus Levels Are Associated with Biopsy-Proven Acute Rejection After the First Year Post-Kidney Transplantation., American Journal of Transplantation 22: 512-512.
- Duijl, T.T. van; Ruhaak, R.; Hoogeveen, E.; Mutsert, R. de; Rosendaal, F.; Cessie, S. le; Fijter, J. de & Cobbaert, C. (2022), Reference intervals of urinary kidney injury biomarkers for middle-aged men and women determined by quantitative protein mass spectrometry, Annals of Clinical Biochemistry 59(6).
- Rooij, E. de; Meuleman, Y.; Fijter, J.W. de; Jager, K.J.; Chesnaye, N.; Evans, M.; Pagels, A.; Caskey, F.; Torino, C.; Porto, G.; Szymczak, M.; Drechsler, C.; Wanner, C.; Dekker, F.W. & Hoogeveen, E. (2022), SYMPTOM BURDEN AND INDIVIDUAL SYMPTOMS BEFORE AND AFTER DIALYSIS INITIATION IN OLDER PATIENTS, Nephrology Dialysis Transplantation 37: I859-I860.
- Rooij, E.N.M. de; Meuleman, Y.; Fijter, J.W. de; Jager, K.J.; Chesnaye, N.C.; Evans, M.; Caskey, F.J.; Torino, C.; Porto, G.; Szymczak, M.; Drechsler, C.; Wanner, C.; Dekker, F.W.; Hoogeveen, E.K. & EQUAL Study Investigators (2022), Symptom burden before and after dialysis initiation in older patients, Clinical Journal of the American Society of Nephrology 17(12): 1719-1729.
- Bezstarosti, S.; Reinders, M.E.J.; Fijter, J.W. de & Heidt, S. (2022), Tacrolimus withdrawal after mesenchymal stromal cell therapy is associated with donor-specific antibody formation in kidney transplant recipients, HLA: Immune Response Genetics 99(5): 444-445.
- Bezstarosti, S.; Reinders, M.E.J.; Meziyerh, S.; Bakker, K.H.; Roelen, D.L.; Fijter, J.W. de & Heidt, S. (2022), Tacrolimus Withdrawal After Mesenchymal Stromal Cell Therapy Is Associated With Donor-Specific Antibody Formation in Kidney Transplant Recipients, Transplantation 106(9): S240-S240.
- Rijn, A. van; Meziyerh, S.; Helm, D. van der; Gelder, T. van; Kroes, A.; Fijter, J. de; Moes, D.; Rotmans, J.; Vries, A. de & Feltkamp, M. (2022), The Effect of Tacrolimus and Mycophenolic Acid on Torque Teno Virus Loads in Kidney Transplant Recipients., American Journal of Transplantation 22: 1030-1030.
- Rijn, A. van; Meziyerh, S.; Helm, D. van der; Gelder, T. van; Kroes, A.C.M.; Fijter, J.W. de; Moes, D.J.A.R.; Rotmans, J.I.; Vries, A.P.J. de & Feltkamp, M.C.W. (2022), The Effect of Tacrolimus and Mycophenolic Acid on TTV Loads in Kidney Transplant Recipients, Transplantation 106(9): S201-S201.
- Geertsema, P.; Gansevoort, R.; Leliveld-Kors, A.; Fijter, J.W. de; Dekker, S.; Meijer, E.; Pol, R.; Sanders, J.S. & Casteleijn, N.F. (2022), THE IMPACT OF PRE-TRANSPLANTATION NEPHRECTOMY ON QUALITY OF LIFE IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE, Nephrology Dialysis Transplantation 37: I8-I8.
- Zwart, T.C.; Metscher, E.; Boog, P.J.M. van der; Swen, J.J.; Fijter, J.W. de; Guchelaar, H.J.; Vries, A.P.J. de & Moes, D.J.A.R. (2022), Volumetric microsampling for simultaneous remote immunosuppressant and kidney function monitoring in outpatient kidney transplant recipients, British Journal of Clinical Pharmacology 88(11).
- Rooij, E.N.M. de; Dekker, F.W.; Cessie, S. le; Hoorn, E.J.; Fijter, J.W. de; Hoogeveen, E.K. & Netherlands Cooperative Study Adeq (2022), Serum potassium and mortality risk in hemodialysis patients, KIDNEY MEDICINE 4(1).
- Esmeijer, K.; Schoe, A.; Ruhaak, L.R.; Hoogeveen, E.K.; Soonawala, D.; Romijn, F.P.H.T.M.; Shirzada, M.R.; Dissel, J.T. van; Cobbaert, C.M. & Fijter, J.W. de (2021), The predictive value of TIMP-2 and IGFBP7 for kidney failure and 30-day mortality after elective cardiac surgery, Scientific Reports 11(1).
- Groeneweg, K.E.; Toorn, F.A. van der; Roelen, D.L.; Kooten, C. van; Heidt, S.; Claas, F.H.J.; Reinders, M.E.J.; Fijter, J.W. de & Soonawala, D. (2021), Single antigen testing to reduce early antibody-mediated rejection risk in female recipients of a spousal donor kidney., Transplant Immunology.
- Zwart, T.; Metscher, E.; Gokoel, S.; Boog, P. van der; Fijter, J. de; Guchelaar, H.; Swen, J.; Vries, A. de & Moes, D. (2021), SIMULTANEOUS LC-MS/MS QUANTIFICATION OF CREATININE, IOHEXOL AND FIVE IMMUNOSUPPRESSANTS IN VOLUMETRIC MICROSAMPLES FOR REMOTE RENAL TRANSPLANT RECIPIENT MONITORING., Clinical Pharmacology & Therapeutics 109: S75-S75.
- Duijl, T.T. van; Soonawala, D.; Fijter, J.W. de; Ruhaak, L.R. & Cobbaert, C.M. (2021), Rational selection of a biomarker panel targeting unmet clinical needs in kidney injury, Clinical Proteomics 18(1).
- Zwart, T.C.; Vries, A.P.J. de; Engbers, A.G.J.; Dam, R.E.; Boog, P.J.M. van der; Swen, J.J.; Keizer, R.J.; Dalton, R.N.; Guchelaar, H.J.; Fijter, J.W. de & Moes, D.J.A.R. (2021), Model-based estimation of iohexol plasma clearance for pragmatic renal function determination in the renal transplantation setting, Clinical Pharmacokinetics 60.
- Reinders, M.E.J.; Groeneweg, K.E.; Hendriks, S.H.; Bank, J.R.; Dreyer, G.J.; Vries, A.P.J. de; Pel, M. van; Roelofs, H.; Huurman, V.A.L.; Meij, P.; Moes, D.J.A.R.; Fibbe, W.E.; Claas, F.H.J.; Roelen, D.L.; Kooten, C. van; Kers, J.; Heidt, S.; Rabelink, T.J. & Fijter, J.W. de (2021), Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal, American Journal of Transplantation 21(9).
- Gielis, E.M.; Anholts, J.D.H.; Beelen, E. van; Haasnoot, G.W.; Fijter, H.W. de; Bajema, I.; Heidt, S.; Vrie, M. van de; Hilbrands, L.B.; Mallat, M.J.K.; Ledeganck, K.J.; Claas, F.H.J. & Eikmans, M. (2021), A combined microRNA and chemokine profile in urine to identify rejection after kidney transplantation, Transplantation Direct 7(7).
- Duijl, T.T. van; Ruhaak, L.R.; Smit, N.P.M.; Pieterse, M.M.; Romijn, F.P.H.T.M.; Dolezal, N.; Drijfhout, J.W.; Fijter, J.W. de & Cobbaert, C.M. (2021), Development and Provisional Validation of a Multiplex LC-MRM-MS Test for Timely Kidney Injury Detection in Urine, Journal of Proteome Research.
- Peereboom, E.T.M.; Matern, B.M.; Tomosugi, T.; Niemann, M.; Drylewicz, J.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Reekum, F.E. van; Verhaar, M.C.; Kamburova, E.G.; Seelen, M.A.J.; Sanders, J.S.; Hepkema, B.G.; Lambeck, A.J.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.A.C.J.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, A.; Lardy, N.M.; Swelsen, W.; Pant, K.A. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Vries, A.P.J. de; Fijter, J.W. de; Betjes, M.G.H.; Roelen, D.L.; Claas, F.H.; Otten, H.G.; Heidt, S.; Zuilen, A.D. van; Kobayashi, T.; Geneugelijk, K. & Spierings, E. (2021), T-cell epitopes shared between immunizing HLA and donor HLA associate with graft failure after kidney transplantation, Frontiers in Immunology 12.
- Bezstarosti, S.; Haasnoot, G.; Madbouly, A.; Fijter, H. de; Reinders, M.; Claas, F. & Heidt, S. (2021), SOLVENT ACCESSIBLE AMINO ACID MISMATCHES CALCULATED BY HLA-EMMA AS INDEPENDENT RISK FACTOR FOR DEATH-CENSORED GRAFT FAILURE IN RENAL TRANSPLANTATION, Transplant International 34: 182-182.
- Zwart, T.C.; Guchelaar, H.J.; Boog, P.J.M. van der; Swen, J.J.; Gelder, T. van; Fijter, J.W. de & Moes, D.J.A.R. (2021), Model-informed precision dosing to optimise immunosuppressive therapy in renal transplantation, Drug Discovery Today 26(11): 2527-2546.
- Rooij, E. de; Meuleman, Y.; Fijter, J.W. de; Jager, K.J.; Chesnaye, N.; Evans, M.; Caskey, F.; Torino, C.; Szymczak, M.; Drechsler, C.; Wanner, C.; Dekker, F.W. & Hoogeveen, E. (2021), HEALTH-RELATED QUALITY OF LIFE (HRQOL) AND SYMPTOM BURDEN BEFORE AND AFTER START OF DIALYSIS IN OLDER PATIENTS, Nephrology Dialysis Transplantation 36.
- Budde, K.; Prashar, R.; Haller, H.; Rial, M.C.; Kamar, N.; Agarwal, A.; Fijter, J.W. de; Rostaing, L.; Berger, S.P.; Djamali, A.; Leca, N.; Allamassey, L.; Gao, S.; Polinsky, M. & Vincenti, F. (2021), Conversion from Calcineurin Inhibitor? to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial, Journal of the American Society of Nephrology 32(12): 3252-3264.
- Meucci, M.C.; Reinders, M.E.J.; Groeneweg, K.E.; Bezstarosti, S.; Marsan, N.A.; Bax, J.J.; Fijter, J.W. de & Delgado, V. (2021), Cardiovascular effects of autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal in renal transplant recipients, Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease 10(24).
- Zwart, T.; Engbers, A.; Dam, R.; Derboog, P. van; Fijter, J. de; Guchelaar, H.; Vries, A. de & Moes, D. (2020), POPULATION PHARMACOKINETICS AND LIMITED SAMPLING OF IOHEXOL AS A RENAL FUNCTION MARKER IN THE RENAL TRANSPLANT SETTING., Clinical Pharmacology and Therapeutics 107: S96-S96.
- Esmeijer, K.; Geleijnse, J.M.; Fijter, J.W. de; Kromhout, D. & Hoogeveen, E.K. (2020), Dietary protein intake and kidney function decline after myocardial infarction, Nephrology Dialysis Transplantation 35(1): 106-115.
- Groeneweg, K.E.; Au, Y.W.; Duijs, J.M.G.J.; Florijn, B.W.; Kooten, C. van; Fijter, J.W. de; Reinders, M.E.J.; Zonneveld, A.J. van & Bijkerk, R. (2020), Diabetic nephropathy alters circulating long noncoding RNA levels that normalize following simultaneous pancreas-kidney transplantation, American Journal of Transplantation 20(12).
- Esmeijer, K.; Hoogeveen, E.K.; Boog, P.J.M. van den; Konijn, C.; Mallat, M.J.K.; Baranski, A.G.; Dekkers, O.M.; Fijter, J.W. de & Dutch Transplant Ctr (2020), Superior Long-term Survival for Simultaneous Pancreas-Kidney Transplantation as Renal Replacement Therapy: 30-Year Follow-up of a Nationwide Cohort, Diabetes Care 43(2): 321-328.
- Dreyer, G.J. & Fijter, J.W. de (2020), Transplanting the elderly: mandatory age- and minimal histocompatibility matching, Frontiers in Immunology 11.
- Budde, K.; Prashar, R.; Haller, H.; Rial, M.; Kamar, N.; Agarwal, A.; Fijter, J. de; Rostaing, L.; Berger, S.; Djamali, A.; Leca, N.; Allamassey, L.; Gao, S.; Polinsky, M. & Vincenti, F. (2020), Prospective, Randomized Study of Conversion from Calcineurin Inhibitor (CNI)- to Belatacept (BELA)-Based Maintenance Immunosuppression in Renal Transplant Recipients, American Journal of Transplantation 20: 437-438.
- Zwart, T.C.; Moes, D.J.A.R.; Boog, P.J.M. van der; Erp, N.P. van; Fijter, J.W. de; Guchelaar, H.J.; Keizer, R.J. & Heine, R. ter (2020), Model-informed precision dosing of everolimus, Clinical Pharmacokinetics 60.
- Nijhoff, M.F.; Hovens, J.G.F.M.; Huisman, S.D.; Ringers, J.; Rabelink, T.A.J.; Fijter, H.J.W. de; Boog, P.J.M. van der & Koning, E.J.P. de (2020), Psychological symptoms and quality of life after simultaneous kidney and pancreas transplantation, Transplantation Direct 6(5).
- Messchendorp, A.L.; Casteleijn, N.F.; Meijer, E.; Gansevoort, R.T.; Drenth, J.P.; Fijter, J.W. de; Peters, D.J.M.; Visser, F.W.; Wetzels, J.F.; Zietse, R. & DIPAK Consortium Investigators (2020), Somatostatin in renal physiology and autosomal dominant polycystic kidney disease, Nephrology Dialysis Transplantation 35(8): 1306-1316.
- Gokoel, S.R.M.; Zwart, T.C.; Moes, D.J.A.R.; Boog, P.J.M. van der & Fijter, J.W. de (2020), No Apparent Influence of Nonadherence on Tacrolimus Intrapatient Variability in Stable Kidney Transplant Recipients, Therapeutic Drug Monitoring 42(5): 702-709.
- Dreyer, G.J.; Groeneweg, K.E.; Heidt, S.; Roelen, D.L.; Pel, M. van; Roelofs, H.; Huurman, V.A.L.; Bajema, I.M.; Moes, D.J.A.R.; Fibbe, W.E.; Claas, F.H.J.; Kooten, C. van; Rabelink, R.J.; Fijter, J.W. de & Reinders, M.E.J. (2020), Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation, American Journal of Transplantation 20(10).
- Rooij, E. de; Dekker, F.W.; Cessie, S. le; Fijter, J.W. de & Hoogeveen, E.K. (2020), ESPECIALLY HYPOKALEMIA IS A RISK FACTOR FOR ALL-CAUSE MORTALITY IN INCIDENT HEMODIALYSIS PATIENTS, Nephrology Dialysis Transplantation 35: 1759-1759.
- Buntinx, M.; Lavrijsen, A.P.M.; Fijter, J.W. de; Reinders, M.E.J.; Schepers, A. & Bavinck, J.N.B. (2020), Skin disorders indicating peripheral arterial occlusive disease and chronic venous insufficiency in organ transplant recipients, Journal of Diabetes and its Complications 34(9).
- Dekker, S.E.I.; Verhoeven, A.; Soonawala, D.; Peters, D.J.M.; Fijter, J.W. de; Mayboroda, O.A. & DIPAK Consortium (2020), Urinary metabolites associate with the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease, PLoS ONE 15(5).
- Groeneweg, K.E.; Duijs, J.M.G.J.; Florijn, B.W.; Kooten, C. van; Fijter, J.W. de; Zonneveld, A.J. van; Reinders, M.E.J. & Bijkerk, R. (2020), Circulating long noncoding RNA LNC-EPHA6 associates with acute rejection after kidney transplantation, International Journal of Molecular Sciences 21(16).
- Yepes-Calderon, M.; Sotomayor, C.G.; Rasmussen, D.G.K.; Hijmans, R.S.; Velde-Keyzer, C.A.T.; Londen, M. van; Dijk, M. van; Diepstra, A.; Berger, S.P.; Karsdal, M.A.; Bemelman, F.J.; Fijter, J.W. de; Kers, J.; Florquin, S.; Genovese, F.; Bakker, S.J.L.; Sanders, J.S. & Born, J. van den (2020), Biopsy-controlled non-invasive quantification of collagen type VI in kidney transplant recipients, Journal of Clinical Medicine 9(10).
- Gokoel, S.R.M.; Gombert-Handoko, K.B.; Zwart, T.C.; Boog, P.J.M. van der; Moes, D.J.A.R. & Fijter, J.W. de (2020), Medication non-adherence after kidney transplantation: A critical appraisal and systematic review, Transplantation Reviews 34(1).
- Bernts, L.H.P.; Dekker, S.E.I.; Soonawala, D.; Bruggemann, R.J.M.; Wertheim, H.F.L.; Fijter, J.W. de; Drenth, J.P.H. & Lantinga, M.A. (2020), Efficacy and safety of selective decontamination of the digestive tract (SDD) to prevent recurrent hepatic cyst infections in polycystic liver disease, Journal of Antimicrobial Chemotherapy 75(9): 2666-2669.
- Meziyerh, S.; Zwart, T.C.; Etten, R.W. van; Janson, J.A.; Gelder, T. van; Alwayn, I.P.J.; Fijter, J.W. de; Reinders, M.E.J.; Moes, D.J.A.R. & Vries, A.P.J. de (2020), Severe COVID-19 in a renal transplant recipient, American Journal of Transplantation 20(7).
- Kramers, B.J.; Koorevaar, I.W.; Drenth, J.P.H.; Fijter, J.W. de; Neto, A.G.; Peters, D.J.M.; Vart, P.; Wetzels, J.F.; Zietse, R.; Gansevoort, R.T. & Meijer, E. (2020), Salt, but not protein intake, is associated with accelerated disease progression in autosomal dominant polycystic kidney disease, Kidney International 98(4): 989-998.
- Wunderink, H.F.; Haasnoot, G.W.; Brouwer, C.S. de; Zwet, E.W. van; Kroes, A.C.M.; Fijter, J.W. de; Rotmans, J.I.; Claas, F.H.J. & Feltkamp, M.C.W. (2019), Reduced Risk of BK Polyomavirus Infection in HLA-B51-positive Kidney Transplant Recipients, Transplantation 103(3): 604-612.
- Kopp, W.H.; Leeuwen, C.A.T. van; Lam, H.D.; Huurman, V.A.L.; Fijter, J.W. de; Schaapherder, A.F.; Baranski, A.G. & Braat, A.E. (2019), Retrospective study on detection, treatment, and clinical outcome of graft thrombosis following pancreas transplantation, Transplant International 32(4): 410-417.
- Groeneweg Koen, Reinders Marlies, Cobbaert Christa, Romijn Fred, van Kooten Cees & De Fijter Johan (2019), SERUM INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 7 (IGFBP7) AND TISSUE INHIBITOR OF METALLOPROTEINASES 2 (TIMP-2) LEVELS DECREASE AFTER SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION (SPKT), Transplant International 32: 313-314.
- Wunderink, H.F.; Brouwer, C.S. de; Gard, L.; Fijter, J.W. de; Kroes, A.C.M.; Rotmans, J.I. & Feltkamp, M.C.W. (2019), Source and Relevance of the BK Polyomavirus Genotype for Infection After Kidney Transplantation, Open Forum Infectious Diseases 6(3).
- Wisse, B.W.; Kamburova, E.G.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F.E. van; Zuilen, A.D. van; Verhaar, M.C.; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Seelen, M.A.J.; Sanders, J.S.; Hepkema, B.G.; Lambeck, A.J.A.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.A.C.J.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, S.A.; Lardy, N.M.; Swelsen, W.; Pant, K.A.M.I. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.J.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Heidt, S.; Roelen, D.L.; Claas, F.H. & Otten, H.G. (2019), Toward a Sensible Single-antigen Bead Cutoff Based on Kidney Graft Survival, Transplantation 103(4): 789-797.
- Berger, S.P.; Sommerer, C.; Witzke, O.; Tedesco, H.; Chadban, S.; Mulgaonkar, S.; Qazi, Y.; Fijter, J.W. de; Oppenheimer, F.; Cruzado, J.M.; Watarai, Y.; Massari, P.; Legendre, C.; Citterio, F.; Henry, M.; Srinivas, T.R.; Vincenti, F.; Gutierrez, M.P.H.; Marti, A.M.; Bernhardt, P.; Pascual, J. & TRANSFORM Investigators (2019), Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study, American Journal of Transplantation 19(11): 3018-3034.
- Tirsa T van Duijl, L Renee Ruhaak, Johan W de Fijter & and Christa M Cobbaert (2019), Kidney Injury Biomarkers in an Academic Hospital Setting: Where Are We Now?, Clinical Biochemist Reviews 40(2).
- Dekker Shosha, Verhoeven Aswin, Soonawala Darius, Peters Dorien J. M., Mayboroda Oleg A. & De Fijter Johan W. (2019), URINARY ALANINE/CITRATE RATIO ASSOCIATES WITH THE RATE OF EGFR DECLINE IN PATIENTS WITH ADPKD, Nephrology Dialysis Transplantation 34: 366-366.
- Bank, J.R.; Ruhaak, R.; Soonawala, D.; Mayboroda, O.; Romijn, F.P.; Kooten, C. van; Cobbaert, C.M. & Fijter, J.W. de (2019), Urinary TIMP-2 Predicts the Presence and Duration of Delayed Graft Function in Donation After Circulatory Death Kidney Transplant Recipients, Transplantation 103(5): 1014-1023.
- Dekker, S.E.I.; Ruhaak, L.R.; Romijn, F.P.H.T.M.; Meijer, E.; Cobbaert, C.M.; Fijter, J.W. de; Soonawala, D. & DIPAK Consortium (2019), Urinary Tissue Inhibitor of Metalloproteinases-2 and Insulin-Like Growth Factor-Binding Protein 7 Do Not Correlate With Disease Severity in ADPKD Patients, Kidney International Reports 4(6): 833-841.
- Kramers BJ, Gansevoort RT, De Boer R, Drenth JPH, De Fijter JW, Wetzels JFM, Zietse R & Meijer E (2019), USE OF THIAZIDE DIURETICS DOES NOT WORSEN DISEASE PROGRESSION IN ADPKD, Nephrology Dialysis Transplantation 34.
- Michielsen, L.A.; Zuilen, A.D. van; Verhaar, M.C.; Wisse, B.W.; Kamburova, E.G.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F.E. van; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Seelen, M.A.J.; Sanders, J.S.F.; Hepkema, B.G.; Lambeck, A.J.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.A.C.J.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, S.A.; Lardy, N.M.; Swelsen, W.; Pant, K.A. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Heidt, S.; Roelen, D.L.; Claas, F.H.; Otten, H.G. & Hilbrands, L.B. (2019), Effect of initial immunosuppression on long-term kidney transplant outcome in immunological low-risk patients, Nephrology Dialysis Transplantation 34(8): 1417-1422.
- Wunderink, H.F.; Haasnoot, G.W.; Brouwer, C.S. de; Zwet, E.W. van; Kroes, A.C.M.; Fijter, J.W. de; Rotmans, J.I.; Claas, F.H.J. & Feltkamp, M.C.W. (2019), HLA-B51 Reduces Risk of BK Polyomavirus Viremia After Kidney Transplantation.
- Aerts, R.M.M. van; Kievit, W.; D'Agnolo, H.M.A.; Blijdorp, C.J.; Casteleijn, N.F.; Dekker, S.E.I.; Fijter, J.W. de; Gastel, M. van; Gevers, T.J.; Laarschot, L.F.M. van de; Lantinga, M.A.; Losekoot, M.; Meijer, E.; Messchendorp, A.L.; Neijenhuis, M.K.; Pena, M.J.; Peters, D.J.M.; Salih, M.; Soonawala, D.; Spithoven, E.M.; Visser, F.W.; Wetzels, J.F.; Zietse, R.; Gansevoort, R.T.; Drenth, J.P.H. & DIPAK-1 Investigators (2019), Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease, Gastroenterology 157(2): 481-+.
- Esmeijer, K.; Vries, A.P. de; Mook-Kanamori, D.O.; Fijter, J.W. de; Rosendaal, F.R.; Rabelink, T.J.; Smit, R.A.J.; Mutsert, R. de & Hoogeveen, E.K. (2019), Low Birth Weight and Kidney Function in Middle-Aged Men and Women: The Netherlands Epidemiology of Obesity Study, American Journal of Kidney Diseases 74(6): 751-760.
- Heidt, S.; Vergunst, M.; Anholts, J.D.H.; Swings, G.M.J.S.; Gielis, E.M.J.; Groeneweg, K.E.; Witkamp, M.J.; Fijter, J.W. de; Reinders, M.E.J.; Roelen, D.L.; Eikmans, M. & Claas, F.H.J. (2019), Presence of intragraft B cells during acute renal allograft rejection is accompanied by changes in peripheral blood B cell subsets, Clinical and Experimental Immunology 196(3): 403-414.
- Veighey, K.V.; Nicholas, J.M.; Clayton, T.; Knight, R.; Robertson, S.; Dalton, N.; Harber, M.; Watson, C.J.E.; Fijter, J.W. de; Loukogeorgakis, S. & MacAllister, R. (2019), Early remote ischaemic preconditioning leads to sustained improvement in allograft function after live donor kidney transplantation: long-term outcomes in the REnal Protection Against Ischaemia-Reperfusion in transplantation (REPAIR) randomised trial, British Journal of Anaesthesia 123(5): 584-591.
- Esmeijer, K.; Dekkers, O.M.; Fijter, J.W. de; Dekker, F.W. & Hoogeveen, E.K. (2019), Effect of different types of statins on kidney function decline and proteinuria: a network meta-analysis, Scientific Reports 9.
- Losekoot M, Tholens A, Phylipsen M, Meijer E, Visser FW, Drenth JPH, de Fijter JW, Wetzels JF, Zietse R, Gansevoort RT & Peters DJM (2019), High diagnostic yield in well-defined cohort of ADPKD patients by conventional sequencing and NGS, European Journal of Human Genetics 27: 71-71.
- Heidt, S.; Haasnoot, G.W.; Witvliet, M.D.; Linden-van Oevelen, M.J.H. van der; Kamburova, E.G.; Wisse, B.W.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F.E. van; Zuilen, A.D. van; Verhaar, M.C.; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Seelen, M.A.J.; Sanders, J.S.; Hepkema, B.G.; Lambeck, A.J.A.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.A.C.J.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, S.A.; Lardy, N.M.; Swelsen, W.; Pant, K.A.M.I. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Otten, H.G.; Roelen, D.L. & Claas, F.H.J. (2019), Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients, American Journal of Transplantation 19(10): 2926-2933.
- Kamburova, E.G.; Gruijters, M.L.; Kardol-Hoefnagel, T.; Wisse, B.W.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F.E. van; Zuilen, A.D. van; Verhaar, M.C.; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Melchers, R.C.A.; Seelen, M.A.J.; Sanders, J.S.; Hepkema, B.G.; Lambeck, A.J.A.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.A.C.J.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, S.A.; Lardy, N.M.; Swelsen, W.; Pant, K.A.M.I. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Hoitsma, A.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Heidt, S.; Roelen, D.L.; Claas, F.H.; Bemelman, F.J. & Otten, H.G. (2019), Antibodies against ARHGDIB are associated with long-term kidney graft loss, American Journal of Transplantation 19(12): 3335-3344.
- Michielsen, L.A.; Wisse, B.W.; Kamburova, E.G.; Verhaar, M.C.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F.E. van; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Seelen, M.A.J.; Sanders, J.S.F.; Hepkema, B.G.; Lambeck, A.J.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, S.A.; Lardy, N.M.; Swelsen, W.; Pant, K.A. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Heidt, S.; Roelen, D.L.; Claas, F.H.; Otten, H.G. & Zuilen, A.D. van (2019), A paired kidney analysis on the impact of pre-transplant anti-HLA antibodies on graft survival, Nephrology Dialysis Transplantation 34(6): 1056-1063.
- Andrews, L.M.; Hesselink, D.A.; Schaik, R.H.N. van; Gelder, T. van; Fijter, J.W. de; Lloberas, N.; Elens, L.; Moes, D.J.A.R. & Winter, B.C.M. de (2019), A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients, British Journal of Clinical Pharmacology 85(3): 601-615.
- Chua, J.S.; Zandbergen, M.; Wolterbeek, R.; Baelde, H.J.; Es, L.A. van; Fijter, J.W. de; Bruijn, J.A. & Bajema, I.M. (2019), Complement-mediated microangiopathy in IgA nephropathy and IgA vasculitis with nephritis, Modern Pathology 32(8): 1147-1157.
- Alem, C.M.A. van; Boonstra, M.; Prins, J.; Bezhaeva, T.; Essen, M.F. van; Ruben, J.M.; Vahrmeijer, A.L.; Veer, E.P. van der; Fijter, J.W. de; Reinders, M.E.; Meijer, O.; Metselaar, J.M.; Kooten, C. van & Rotmans, J.I. (2018), Local delivery of liposomal prednisolone leads to an anti-inflammatory profile in renal ischaemia-reperfusion injury in the rat., Nephrology Dialysis Transplantation 33(1).
- Zwart, T.C.; Gokoel, S.R.M.; Boog, P.J.M. van der; Fijter, J. de; Kweekel, D.M.; Swen, J.J.; Guchelaar, H.J. & Moes, D.J.A.R. (2018), Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device, British Journal of Clinical Pharmacology 84(12): 2889-2902.
- Kostidis, S.; Bank, J.R.; Soonawala, D.; Nevedomskaya, E.; Kooten, C. van; Mayboroda, O.A. & Fijter, J.W. de (2018), Urinary metabolites predict prolonged duration of delayed graft function in DCD kidney transplant recipients., American Journal of Transplantation.
- Geneugelijk, K.; Niemann, M.; Drylewicz, J.; Zuilen, A.D. van; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Hack, C.E.; Reekum, F.E. van; Verhaar, M.C.; Kamburova, E.G.; Bots, M.L.; Seelen, M.A.J.; Sanders, J.S.; Hepkema, B.G.; Lambeck, A.J.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Vanderlocht, J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, A.; Lardy, J.N.M.; Swelsen, W.; Pant, K.A. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Heidt, S.; Roelen, D.L.; Claas, F.H.; Otten, H.G. & Spierings, E. (2018), PIRCHE-II Is Related to Graft Failure after Kidney Transplantation, Frontiers in Immunology 9.
- Gruijl, F.R. de; Wolterbeek, R.; Pavel, S.; Fijter, J.W. de; Hamdy, N.A.T. & Bavinck, J.N.B. (2018), Low wintertime pre-diagnostic vitamin D status is associated with an increased risk of internal malignancies in kidney transplant recipients, Photochemical & Photobiological Sciences Photochemical and Photobiological Sciences 17(12): 1946-1955.
- Kamburova, E.G.; Wisse, B.W.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F.E. van; Zuilen, A.D. van; Verhaar, M.C.; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Seelen, M.A.J.; Sanders, J.S.; Hepkema, B.G.; Lambeck, A.J.A.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.A.C.J.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, S.A.; Lardy, N.M.; Swelsen, W.; Pant, K.A.M.I. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.J.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Heidt, S.; Roelen, D.L.; Claas, F.H. & Otten, H.G. (2018), Pretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure, Journal of the American Society of Nephrology 29(9): 2279-2285.
- Kers, J.; Peters-Sengers, H.; Heemskerk, M.B.A.; Berger, S.P.; Betjes, M.G.H.; Zuilen, A.D. van; Hilbrands, L.B.; Fijter, J.W. de; Nurmohamed, A.S.; Christiaans, M.H.; Heide, J.J.H. van der; Debray, T.P.A. & Bemelman, F.J. (2018), Predicition models for delayed graft function: external validation on The Dutch Prospective Renal Transplantation Registry, Nephrology Dialysis Transplantation 33(7): 1259-1268.
- Dijk, M. van; Roon, A.M. van; Said, M.Y.; Bemelman, F.J.; Heide, J.J.H. van der; Fijter, H.W. de; Vries, A.P.J. de; Bakker, S.J.L. & Sanders, J.S.F. (2018), Long-term cardiovascular outcome of renal transplant recipients after early conversion to everolimus compared to calcineurin inhibition: results from the randomized controlled MECANO trial, Transplant International 31(12): 1380-1390.
- Esmeijer Kevin, Geleijnse Johanna, De Fijter Johan, Kromhout Daan & Hoogeveen Ellen (2018), HIGH PROTEIN INTAKE ACCELERATES KIDNEY FUNCTION DECLINE IN POST-MYOCARDIAL INFARCTION PATIENTS - THE ALPHA OMEGA COHORT STUDY, Nephrology Dialysis Transplantation 33.
- Reinwald, M.; Silva, J.T.; Mueller, N.J.; Fortun, J.; Garzoni, C.; Fijter, J.W. de; Fernandez-Ruiz, M.; Grossi, P. & Aguado, J.M. (2018), ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors), Clinical Microbiology and Infection 24: S53-S70.
- Heine, R. ter; Erp, N.P. van; Guchelaar, H.J.; Fijter, J.W. de; Reinders, M.E.J.; Herpen, C.M. van; Burger, D.M. & Moes, D.J.A.R. (2018), A pharmacological rationale for improved everolimus dosing in oncology and transplant patients, British Journal of Clinical Pharmacology 84(7): 1575-1586.
- Bank J., Ruhaak R., Soonawala D., Romijn F., van Kooten C., Cobbaert C. & de Fijter H. (2018), Urinary TIMP-2 Predicts the Presence and Duration of Delayed Graft Function in DCD Kidney Transplant Recipients., American Journal of Transplantation 18: 495-495.
- Esmeijer, K.; Geleijnse, J.M.; Fijter, J.W. de; Giltay, E.J.; Kromhout, D. & Hoogeveen, E.K. (2018), Cardiovascular Risk Factors Accelerate Kidney Function Decline in Post-Myocardial Infarction Patients: The Alpha Omega Cohort Study, Kidney International Reports 3(4): 879-888.
- Yang Jianxin, Spruyt-Gerritse Marijke J., Soonawala Darius, Haasnoot Geert W., de Fijter Hans W., Reinders Marlies E. J., Clahsen Marian C., Claas Frans H. J. & Eikmans Michael (2018), ENDOTHELIAL-EPITHELIAL-RELATED TRANSCRIPTIONAL LEVELS IN ACUTE REJECTION BIOPSIES OF KIDNEY TRANSPLANT RECIPIENTS ARE PREDICTIVE FOR A WORSE RESPONSE TO STEROID TREATMENT, Hla 91(5): 343-343.
- Kopp, W.H.; Lam, H.D.; Schaapherder, A.F.M.; Huurman, V.A.L.; Boog, P.J.M. van der; Koning, E.J.P. de; Fijter, J.W. de; Baranski, A. & Braat, A.E. (2018), Pancreas Transplantation With Grafts From Donors Deceased After Circulatory Death: 5 Years Single-Center Experience, Transplantation 102(2): 333-339.
- Yang, J.X.; Snijders, M.L.H.; Haasnoot, G.W.; Kooten, C. van; Mallat, M.; Fijter, J.W. de; Clahsen-van Groningen, M.C.; Claas, F.H.J. & Eikmans, M. (2018), Elevated intragraft expression of innate immunity and cell death-related markers is a risk factor for adverse graft outcome, Transplant Immunology 48: 39-46.
- Meijer, E.; Visser, F.W.; Aerts, R.M.M. van; Blijdorp, C.J.; Casteleijn, N.F.; D'Agnolo, H.M.A.; Dekker, S.E.I.; Drenth, J.P.H.; Fijter, J. de; Gastel, M.D.A. van; Gevers, T.J.; Lantinga, M.A.; Losekoot, M.; Messchendorp, A.L.; Neijenhuis, M.K.; Pena, M.J.; Peters, D.J.M.; Salih, M.; Soonawala, D.; Spithoven, E.M.; Wetzels, J.F.; Zietse, R.; Gansevoort, R.T. & DIPAK-1 Investigators (2018), Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease The DIPAK 1 Randomized Clinical Trial, Journal of the American Medical Association 320(19): 2010-2019.
- Sandwijk, M.S. van; Vries, A.P.J. de; Bakker, S.J.L.; Berge, I.J.M. ten; Berger, S.P.; Bouatou, Y.R.; Fijter, J.W. de; Florquin, S.; Heide, J.J.H. van der; Idu, M.M.; Krikke, C.; Pant, K.A.M.I. van der; Reinders, M.E.; Ringers, J.; Weerd, N.C. van der; Bemelman, F.J. & Sanders, J.S.S. (2018), Early Steroid Withdrawal Compared With Standard Immunosuppression in Kidney Transplantation - Interim Analysis of the Amsterdam-Leiden-Groningen Randomized Controlled Trial, Transplantation Direct 4(6).
- Kamburova, E.G.; Wisse, B.W.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F.E. van; Zuilen, A.D. van; Verhaar, M.C.; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Seelen, M.A.J.; Sanders, J.S.F.; Hepkema, B.G.; Lambeck, A.J.A.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, S.A.; Lardy, N.M.; Swelsen, W.; Pant, K.A. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Heidt, S.; Roelen, D.L.; Claas, F.H. & Otten, H.G. (2018), Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant, American Journal of Transplantation 18(9): 2274-2284.
- Kamburova, E.G.; Kardol-Hoefnagel, T.; Wisse, B.W.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F.E. van; Zuilen, A.D. van; Verhaar, M.C.; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Meeldijk, J.; Bovenschen, N.; Seelen, M.A.J.; Sanders, J.S.; Hepkema, B.G.; Lambeck, A.J.A.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.A.C.J.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, S.A.; Lardy, N.M.; Swelsen, W.; Pant, K.A.M.I. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Heidt, S.; Roelen, D.L.; Claas, F.H. & Otten, H.G. (2018), Development and Validation of a Multiplex Non-HLA Antibody Assay for the Screening of Kidney Transplant Recipients, Frontiers in Immunology 9.
- Kamburova Elena G., Wisse B. W., Joosten I., Allebes W. A., van der Meer A., Hilbrands L. B., Baas M. C., Spierings Eric, Hack C. E., van Reekum F., van Zuilen A. D., Verhaar M. C., Bots M. L., Plaisier L., Seelen M. A. J., Sanders J. S. F., Hepkema B. G., Lambeck A. J., Bungener L. B., Roozendaal C., Tilanus M. G. J., Voorter C. E., Wieten L., van Duijnhoven E., Gelens M., Christiaans M., van Ittersum F., Nurmohamed A., Lardy N. M., Swelsen W. T., van der Pant K. A. M. I., van der Weerd N. C., ten Berge I. J. M., Bemelman F. J., Hoitsma A. J., van der Boog P. J. M., de Fijter J. W., Betjes M. G. H., Heidt Sebastiaan, Roelen D. L., Claas F. H. J. & Otten H. G. (2018), DECREASED GRAFT SURVIVAL OF RETRANSPLANTS CAN LARGELY BE EXPLAINED BY INCREASED HLA-IMMUNIZATION, Hla 91(5): 372-372.
- Esmeijer, K.; Geleijnse, J.M.; Giltay, E.J.; Stijnen, T.; Dekker, F.W.; Fijter, J.W. de; Kromhout, D. & Hoogeveen, E.K. (2018), Body-fat indicators and kidney function decline in older post-myocardial infarction patients: The Alpha Omega Cohort Study, European Journal of Preventive Cardiology 25(1): 90-99.
- Alem, C.M.A. van; Boonstra, M.; Prins, J.; Bezhaeva, T.; Essen, M.F. van; Ruben, J.M.; Vahrmeijer, A.L.; Veer, E.P. van der; Fijter, J.W. de; Reinders, M.E.; Meijer, O.; Metselaar, J.M.; Kooten, C. van & Rotmans, J.I. (2018), Local delivery of liposomal prednisolone leads to an anti-inflammatory profile in renal ischaemia-reperfusion injury in the rat, Nephrology Dialysis Transplantation 33(1): 44-53.
- Reinders, M.E.J.; Kooten, C. van; Rabelink, T.J. & Fijter, J.W. de (2018), Mesenchymal Stromal Cell Therapy for Solid Organ Transplantation, Transplantation 102(1): 35-43.
- Dekker S., Bank J., Soonawala D., Ruhaak L., Romijn F., Cobbaert C. & De Fijter J. (2018), URINARY TISSUE INHIBITOR OF METALLOPROTEINASES-2 (TIMP-2) AND INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 7 (IGFBP7) IN ACUTE AND CHRONIC KIDNEY DYSFUNCTION, Nephrology Dialysis Transplantation 33.
- Kostidis, S.; Bank, J.R.; Soonawala, D.; Nevedomskaya, E.; Kooten, C. van; Mayboroda, O.A. & Fijter, H.J.W. de (2017), URINARY METABOLIC PROFILES TO PREDICT PROLONGED DURATION OF DELAYED FUNCTION IN DCD KIDNEY TRANSPLANT RECIPIENT, Transplant International 30: 271-271.
- Berger, S.; Sommerer, C.; Bakr, M.; Kim, M.S.; Danguilan, R.; Fijter, J. de; Henry, M.; Luo, W.L.; Bernhardt, P. & Legendre, C. (2017), TRANSFORM STUDY: IMPACT OF DONOR TYPE ON 12-MONTH OUTCOMES OF EVEROLIMUS AND REDUCED CALCINEURIN INHIBITOR VERSUS MYCOPHENOLATE AND STANDARD CALCINEURIN INHIBITOR IN DE NOVO KIDNEY TRANSPLANT PATIENTS, Transplant International 30: 162-163.
- Oppenheimer, F.; Witzke, O.; Viklicky, O.; Cassuto, E.; Fijter, J. de; Huynh-Do, U.; Russ, G.; Srinivas, T.; Luo, W.L.; Bernhardt, P. & Qazi, Y. (2017), THE TRANSFORM STUDY: EFFECT OF EVEROLIMUS WITH REDUCED-EXPOSURE CALCINEURIN INHIBITOR ON 12-MONTH RENAL FUNCTION OUTCOMES IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS, Transplant International 30: 162-162.
- D'Agnolo, H.M.A.; Casteleijn, N.F.; Gevers, T.J.G.; Fijter, H. de; Gastel, M.D.A. van; Messchendorp, A.L.; Peters, D.J.M.; Salih, M.; Soonawala, D.; Spithoven, E.M.; Visser, F.W.; Wetzels, J.F.M.; Zietse, R.; Gansevoort, R.T. & Drenth, J.P.H. (2017), The Association of Combined Total Kidney and Liver Volume with Pain and Gastrointestinal Symptoms in Patients with Later Stage Autosomal Dominant Polycystic Kidney Disease, American Journal of Nephrology 46(3): 239-248.
- Fellstrom, B.C.; Barratt, J.; Cook, H.; Coppo, R.; Feehally, J.; Fijter, J.W. de; Floege, J.; Hetzel, G.; Jardine, A.G.; Locatelli, F.; Maes, B.D.; Mercer, A.; Ortiz, F.; Praga, M.; Sorensen, S.S.; Tesar, V.; Vecchio, L. del & NEFIGAN Trial Invest (2017), Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial, Lancet 389(10084): 2117-2127.
- Peters-Sengers, H.; Berger, S.P.; Heemskerk, M.B.A.; Arashi, D. al; Heide, J.J.H. van der; Hemke, A.C.; Berge, I.J.M. ten; Idu, M.M.; Betjes, M.G.H.; Zuilen, A.D. van; Hilbrands, L.B.; Vries, A.P.J. de; Nurmohamed, A.S.; Christiaans, M.H.; Heurn, L.W.E. van; Fijter, J.W. de & Bemelman, F.J. (2017), Stretching the Limits of Renal Transplantation in Elderly Recipients of Grafts from Elderly Deceased Donors, Journal of the American Society of Nephrology 28(2): 621-631.
- Geneugelijk, K.; Niemann, M.; Drylewicz, J.; Zuilen, A. van; Joosten, I.; Allebes, W.; Meer, A. van der; Hilbrands, L.; Baas, M.; Hack, E.; Reekum, F. van; Verhaar, M.; Kamburova, E.; Bots, M.; Seelen, M.; Sanders, J.S.; Hepkema, B.; Lambeck, A.; Bungener, L.; Tilanus, M.; Voorter, C.; Vanderlocht, J.; Wieten, L.; Duijnhoven, E.; Gelens, M.; Christiaans, M.; Ittersum, F. van; Nurmohamed, A.; Lardy, N.; Swelsen, W.; Pant, K. van der; Weerd, N. van der; Berge, I. ten; Bemelman, F.; Hoitsma, A.; Boog, P. van der; Fijter, J. de; Betjes, M.; Heidt, S.; Roelen, D.; Claas, F.; Otten, H. & Spierings, E. (2017), PIRCHE-II: A NOVEL TOOL TO IDENTIFY PERMISSIBLE HLA MISMATCHES IN KIDNEY TRANSPLANTATION., Human Immunology 78: 39-39.
- Geneugelijk, K.; Niemann, M.; Drylewicz, J.; Zuilen, A.D. van; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Hack, C.E.; Reekum, F.E. van; Verhaar, M.; Kamburova, E.G.; Bots, M.L.; Seelen, M.A.J.; Sanders, J.S.F.; Hepkema, B.G.; Lambeck, A.J.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Vanderlocht, J.; Voorter, C.E.M.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, A.; Lardy, N.M.; Swelsen, W.; Pant, K.A. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.D.J.; Hoitsma, A.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Heidt, S.; Roelen, D.L.; Claas, F.H.J.; Otten, H.G. & Spierings, E. (2017), PIRCHE-II: A NOVEL TOOL TO IDENTIFY PERMISSIBLE HLA MISMATCHES IN KIDNEY TRANSPLANTATION, Hla 89(6): 374-375.
- Fijter, J.W. de (2017), Recurrence of glomerulonephritis: an underestimated and unmet medical need, Kidney International 92(2): 294-296.
- Rekers, N.V.; Flaig, T.M.; Mallat, M.J.K.; Spruyt-Gerritse, M.J.; Zandbergen, M.; Anholts, J.D.H.; Bajema, I.M.; Clahsen-van Groningen, M.C.; Yang, J.X.; Fijter, J.W. de; Claas, F.H.J.; Brakemeier, S.; Lachmann, N.; Kreutz, R.; Heer, E. de; Budde, K.; Bolbrinker, J. & Eikmans, M. (2017), Donor Genotype and Intragraft Expression of CYP3A5 Reflect the Response to Steroid Treatment During Acute Renal Allograft Rejection, Transplantation 101(9): 2017-2025.
- Kamburova, E.G.; Wisse, B.W.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F. van; Zuilen, A. van; Verhaar, M.C.; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Seelen, M.A.J.; Sanders, J.S.F.; Hepkema, B.G.; Lambeck, A.J.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Voorter, C.E.M.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, A.; Lardy, N.M.; Swelsen, W.; Pant, K.A. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.; Boog, P.J.M. van der; Fijter, H. de; Betjes, M.G.H.; Heidt, S.; Roelen, D.L.; Claas, F.H.J. & Otten, H.G. (2017), DIFFERENTIAL EFFECT OF DONOR-SPECIFIC HLA ANTIBODIES IN LIVING VERSUS DECEASED DONOR KIDNEY TRANSPLANTATION, Hla 89(6): 348-348.
- Fijter, J.W. de; Holdaas, H.; Oyen, O.; Sanders, J.S.; Sundar, S.; Bemelman, F.J.; Sommerer, C.; Pascual, J.; Avihingsanon, Y.; Pongskul, C.; Oppenheimer, F.; Toselli, L.; Russ, G.; Wang, Z.; Lopez, P.; Kochuparampil, J.; Cruzado, J.M.; Giet, M. van der & ELEVATE Study Grp (2017), Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial, American Journal of Transplantation 17(7): 1853-1867.
- Holdaas, H.; Fijter, J.W. de; Cruzado, J.M.; Massari, P.; Nashan, B.; Kanellis, J.; Witzke, O.; Gutierrez-Dalmau, A.; Turkmen, A.; Wang, Z.; Lopez, P.; Bernhardt, P.; Kochuparampil, J.; Giet, M. van der; Murbraech, K. & ELEVATE Study Grp (2017), Cardiovascular Parameters to 2 years After Kidney Transplantation Following Early Switch to Everolimus Without Calcineurin Inhibitor Therapy: An Analysis of the Randomized ELEVATE Study, Transplantation 101(10): 2612-2620.
- Bank, J.R.; Heidt, S.; Moes, D.J.A.R.; Roelen, D.L.; Mallat, M.J.K.; Boog, P.J.M. van der; Vergunst, M.; Jol-van der Zijde, C.M.; Bredius, R.G.M.; Braat, A.E.; Ringers, J.; Tol, M.J.D. van; Claas, F.H.J.; Reinders, M.E.J. & Fijter, J.W. de (2017), Alemtuzumab Induction and Delayed Acute Rejection in Steroid-Free Simultaneous Pancreas-Kidney Transplant Recipients, Transplantation Direct 3(1).
- Bemelman, F.J.; Fijter, J.W. de; Kers, J.; Meyer, C.; Peters-Sengers, H.; Maar, E.F. de; Pant, K.A.M.I. van der; Vries, A.P.J. de; Sanders, J.S.; Zwinderman, A.; Idu, M.M.; Berger, S.; Reinders, M.E.J.; Krikke, C.; Bajema, I.M.; Dijk, M.C. van; Berge, I.J.M. ten; Ringers, J.; Lardy, J.; Roelen, D.; Moes, D.J.; Florquin, S. & Heide, J.J.H. van der (2017), Early Conversion to Prednisolone/Everolimus as an Alternative Weaning Regimen Associates With Beneficial Renal Transplant Histology and Function: The Randomized-Controlled MECANO Trial, American Journal of Transplantation 17(4): 1020-1030.
- Fijter, J. de; Holdaas, H.; Sanders, J.; Sundar, S.; Bemelman, F.; Lopez, P.; Bader, G.; Cruzado, J. & Giet, M. van der (2017), Effect of Everolimus-Based Regimen on Graft Outcomes in Kidney Transplant Recipients with Diabetes at Baseline: Post-Hoc Analysis from the ELEVATE Study, American Journal of Transplantation 17: 738-738.
- Yang, J.X.; Dreyer, G.J.; Setten, J. van; Fijter, H.W. de; Keating, B.J.; Claas, F.H.J. & Eikmans, M. (2017), GENOME-WIDE ASSOCIATION STUDY IDENTIFIES NOVEL RISK LOCI FOR ACUTE KIDNEY TRANSPLANT REJECTION, Hla 89(6): 347-347.
- Lantinga, M.A.; D'Agnolo, H.M.A.; Casteleijn, N.F.; Fijter, J.W. de; Meijer, E.; Messchendorp, A.L.; Peters, D.J.M.; Salih, M.; Spithoven, E.M.; Soonawala, D.; Visser, F.W.; Wetzels, J.F.M.; Zietse, R.; Drenth, J.P.H.; Gansevoort, R.T. & DIPAK Consortium (2017), Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicenter DIPAK-1 Study, Drug Safety 40(2): 153-167.
- Doesum, W.B. van; Gard, L.; Bemelman, F.J.; Fijter, J.W. de; Heide, J.J.H. van der; Niesters, H.G.; Son, W.J. van; Stegeman, C.A.; Groen, H.; Riezebos-Brilman, A. & Sanders, J.S.F. (2017), Incidence and outcome of BK polyomavirus infection in a multicenter randomized controlled trial with renal transplant patients receiving cyclosporine-, mycophenolate sodium-, or everolimus-based low-dose immunosuppressive therapy, Transplant Infectious Disease 19(3).
- Bank, J.R.; Pol, P. van der; Vreeken, D.; Monge-Chaubo, C.; Bajema, I.M.; Schlagwein, N.; Gijlswijk, D.J. van; Kooij, S.W. van der; Reinders, M.E.J.; Fijter, J.W. de & Kooten, C. van (2017), Kidney injury molecule-1 staining in renal allograft biopsies 10 days after transplantation is inversely correlated with functioning proximal tubular epithelial cells, Nephrology Dialysis Transplantation 32(12): 2132-2141.
- Bank, J.; Pol, P. van der; Vreeken, D.; Bajema, I.; Schlagwein, N.; Gijlswijk, D. van; Reinders, M.; Fijter, H. de & Kooten, C. van (2017), KIM-1 STAINING INTENSITY IN RENAL ALLOGRAFT BIOPSIES 10 DAYS POST TRANSPLANTATION IS INVERSELY CORRELATED WITH FUNCTIONING PROXIMAL TUBULAR EPITHELIAL CELLS, Transplant International 30: 397-397.
- Gielis, E.; Anholts, J.; Fijter, H. de; Claas, F. & Eikmans, M. (2017), MICRORNAS IN URINE HELP TO IDENTIFY ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION, Transplant International 30: 270-270.
- Bijkerk, R.; Florijn, B.W.; Khairoun, M.; Duijs, J.M.G.J.; Ocak, G.; Vries, A.P.J. de; Schaapherder, A.F.; Mallat, M.J.K.; Fijter, J.W. de; Rabelink, T.J.; Zonneveld, A.J. van & Reinders, M.E.J. (2017), Acute Rejection After Kidney Transplantation Associates With Circulating MicroRNAs and Vascular Injury, Transplantation Direct 3(7).
- (2017), Cardiovascular risk factors, lifestyle and kidney function decline in stable older post-myocardial infarction patients receiving optimal drug therapy: a prospective cohort study.
- (2017), Cardiovascular risk factors, lifestyle and kidney function decline in stable older post-myocardial infarction patients receiving optimal drug therapy: a prospective cohort study.
- (2017), Dietary protein and kidney function decline in older post-myocardial infarction patients: the Alpha Omega Cohort study.
- Wunderink, H.F.; Meijden, E. van der; Blij-de Brouwer, C.S. van der; Mallat, M.J.K.; Haasnoot, G.W.; Zwet, E.W. van; Claas, E.C.J.; Fijter, J.W. de; Kroes, A.C.M.; Arnold, F.; Touze, A.; Claas, F.H.J.; Rotmans, J.I. & Feltkamp, M.C.W. (2017), Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation, American Journal of Transplantation 17(1): 161-172.
- Fijter, J.W. de (2017), Cancer and mTOR Inhibitors in Transplant Recipients, Transplantation 101(1): 45-55.
- (2016), Obesity and kidney function decline in 60-80 years old state-of-the-art drug-treated post-myocardial infarction patients.
- Casteleijn Niek F., Messchendorp A. Lianne, Spithoven Edwin M., d'Agnolo Hedwig M., Drenth Joost P., de Fijter Johan W., Peters Dorien J., Salih Mahdi, Soonawala Darius, Visser Folkert W., Wetzels Jack F., Zietse Robert & Gansevoort Ron T. (2016), THE DIPAK 1 STUDY: BASELINE CHARACTERISTICS AND SHORT-TERM TREATMENT EFFECTS OF LANREOTIDE VERSUS STANDARD CARE IN PATIENTS WITH LATER STAGE ADPKD, Nephrology Dialysis Transplantation 31: 90-91.
- Massart, A.; Pallier, A.; Pascual, J.; Viklicky, O.; Budde, K.; Spasovski, G.; Klinger, M.; Sever, M.S.; Sorensen, S.S.; Hadaya, K.; Oberbauer, R.; Dudley, C.; Fijter, J.W. de; Yussim, A.; Hazzan, M.; Wekerle, T.; Berglund, D.; Biase, C. de; Perez-Saez, M.J.; Muhlfeld, A.; Orlando, G.; Clemente, K.; Lai, Q.R.N.; Pisani, F.; Kandus, A.; Baas, M.; Bemelman, F.; Ponikvar, J.B.; Mazouz, H.; Stratta, P.; Subra, J.F.; Villemain, F.; Hoitsma, A.; Braun, L.; Cantarell, M.C.; Colak, H.; Courtney, A.; Frasca, G.M.; Howse, M.; Naesens, M.; Reischig, T.; Seron, D.; Seyahi, N.; Tugmen, C.; Hernandez, A.A.; Bena, L.; Biancone, L.; Cuna, V.; Diaz-Corte, C.; Dufay, A.; Gaasbeek, A.; Garnier, A.; Gatault, P.; Govantes, M.A.G.; Glowacki, F.; Gross, O.; Ligny, B.H. de; Huynh-Do, U.; Janbon, B.; Cerro, L.A.J. del; Keller, F.; Manna, G. la; Lauzurica, R.; Sagazan, H.L. de; Thaiss, F.; Legendre, C.; Martin, S.; Moal, M.C.; Noel, C.; Pillebout, E.; Piredda, G.B.; Puga, A.R.; Sulowicz, W.; Tuglular, S.; Prokopova, M.; Chesneau, M.; Moine, A. le; Guerif, P.; Soulillou, J.P.; Abramowicz, M.; Giral, M.; Racape, J.; Maggiore, U.; Brouard, S. & Abramowicz, D. (2016), The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients, Nephrology Dialysis Transplantation 31(6): 1002-1013.
- D'Agnolo Hedwig M. A., Casteleijn Niek F., de Fijter Hans W., Messchendorp Lianne A., Peters Dorien J., Peters Dorien J., Salih Mahdi, Soonawala Darius, Spithoven Edwin M., Visser Folkert W., Wetzels Jack, Zietse Bob, Gansevoort Ron T. & Drenth Joost P. H. (2016), THE ASSOCIATION OF COMBINED TOTAL KIDNEY AND LIVER VOLUME WITH GASTROINTESTINAL SYMPTOMS AND PAIN IN PATIENTS WITH LATER STAGE ADPKD, Nephrology Dialysis Transplantation 31: 92-92.
- Trinanes, J.; Rodriguez, A.; Koning, E. de; Fijter, J. de; Carlotti, F.; Torres, A.; Vries, A. de & Porrini, E. (2016), Tacrolimus (Tac), Rather Than Cyclosporine (CsA), Interacts with Insulin Resistance (IR) to Alter Key Transcription Factors for beta-Cell Identity & Function without Altering NFAT Localization., American Journal of Transplantation 16: 717-718.
- Kamburova, E.G.; Wisse, B.W.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F. van; Zuilen, A.D. van; Verhaar, M.C.; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Seelen, M.A.J.; Sanders, J.S.F.; Hepkema, B.G.; Lambeck, A.J.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Vanderlocht, J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E. van; Gelens, M.; Christiaans, M.; Ittersum, F. van; Nurmohamed, A.; Lardy, N.M.; Swelsen, W.T.; Pant, K.A.M.I. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.J.; Fijter, J.W. de; Betjes, M.G.H.; Roelen, D.L.; Claas, F.H.J. & Otten, H.G. (2016), PRE-TRANSPLANT DONOR SPECIFIC HLA ANTIBODIES IN 4386 RENAL TRANSPLANT RECIPIENTS: A PRELIMINARY ANALYSIS OF THE PROCARE COHORT, Hla 87(4): 225-226.
- Bank, J.; Mallat, M.; Zijde, C.J.V.D.; Bredius, R.; Boog, P. van der; Braat, A.; Ringers, J.; Reinders, M. & Fijter, J. de (2016), Plasma Alemtuzumab Levels Show Great Interpatient Variability, but Are Not Associated with Late Acute Rejection in Simultaneous Pancreas-Kidney Recipients., American Journal of Transplantation 16: 424-425.
- Gielis, E.M.; Anholts, J.D.H.; Fijter, H.W. de; Bajema, I.M.; Claas, F.H.J. & Eikmans, M. (2016), MICRORNAS IN URINARY SEDIMENTS AS NON-INVASIVE TOOL TO DETECT ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION, Hla 87(4): 207-207.
- Gielis, E.; Anholts, J.; Fijter, H. de; Bajema, I.; Claas, F. & Eikmans, M. (2016), MicroRNAs in Urinary Sediments as Non-Invasive Tool to Detect Acute Rejection After Kidney Transplantation, American Journal of Transplantation 16: 251-252.
- Kooten, C. van; Rabelink, T.J.; Fijter, J.W. de & Reinders, M.E.J. (2016), Mesenchymal stromal cells in clinical kidney transplantation: how tolerant can it be?, Current Opinion in Organ Transplantation 21(6): 550-558.
- Dreyer, G.; Fijter, J. de; Briscoe, D.; Daly, K. & Reinders, M. (2016), Levels of VEGF-C, PLGF and Follistatin at 12 Months Post Transplantation Are Associated with Increased Risk for Long Term Progressive Renal Dysfunction., American Journal of Transplantation 16: 313-314.
- de Fijter J., Holdaas H., Seelen M., Sundar S., Bemelman F., Lopez P., Aguilar J., Bernhardt P., Wang Z., Cruzado J. & van der Giet M. (2016), Impact of Early Calcineurin Inhibitor Withdrawal on Renal Function and Urinary Protein Excretion: 24 Month Analyses of the ELEVATE Study., American Journal of Transplantation 16: 216-217.
- Kamburova, E.G.; Wisse, B.W.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F.E. van; Zuilen, A.D. van; Verhaar, M.; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Seelen, M.A.J.; Sanders, J.S.F.; Hepkema, B.G.; Lambeck, A.J.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Vanderlocht, J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, A.; Lardy, N.M.; Swelsen, W.; Pant, K.A. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Heidt, S.; Roelen, D.L.; Claas, F.H. & Otten, H.G. (2016), How can we reduce costs of solid-phase multiplex-bead assays used to determine anti-HLA antibodies?, Hla 88(3): 110-119.
- Nijhoff, M.F.; Engelse, M.A.; Dubbeld, J.; Braat, A.E.; Ringers, J.; Roelen, D.L.; Erkel, A.R. van; Spijker, H.S.; Bouwsma, H.; Boog, P.J.M. van der; Fijter, J.W. de; Rabelink, T.J. & Koning, E.J.P. de (2016), Glycemic Stability Through Islet-After-Kidney Transplantation Using an Alemtuzumab-Based Induction Regimen and Long-Term Triple-Maintenance Immunosuppression, American Journal of Transplantation 16(1): 246-253.
- Assfalg, V.; Huser, N.; Meel, M. van; Haller, B.; Rahmel, A.; Boer, J. de; Matevossian, E.; Novotny, A.; Knops, N.; Weekers, L.; Friess, H.; Pratschke, J.; Fuegger, R.; Janko, O.; Rasoul-Rockenschaub, S.; Bosmans, J.L.; Broeders, N.; Peeters, P.; Mourad, M.; Kuypers, D.; Slavicek, J.; Muehlfeld, A.; Sommer, F.; Viebahn, R.; Pascher, A.; Giet, M. van der; Zantvoort, F.; Woitas, R.P.; Putz, J.; Grabitz, K.; Kribben, A.; Hauser, I.; Pisarski, P.; Weimer, R.; Lorf, T.; Fornara, P.; Morath, C.; Nashan, B.; Lehner, F.; Kliem, V.; Sester, U.; Grimm, M.O.; Feldkamp, T.; Kleinert, R.; Arns, W.; Monch, C.; Schoenberg, M.B.; Nitschke, M.; Kruger, B.; Thorban, S.; Arbogast, H.P.; Wolters, H.H.; Maier, T.; Lutz, J.; Heller, K.; Banas, B.; Hakenberg, O.; Kalus, M.; Nadalin, S.; Keller, F.; Lopau, K.; Bemelman, F.J.; Nurmohamed, S.; Sanders, J.S.; Fijter, J.W. de; Christiaans, M.; Hilbrands, L.; Betjes, M.; Zuilen, A. van & Heemann, U. (2016), High-urgency kidney transplantation in the Eurotransplant Kidney Allocation System: success or waste of organs? The Eurotransplant 15-year all-centre survey, Nephrology Dialysis Transplantation 31(9): 1515-1522.
- Bank J., Reinders M., Noordermeer L., Mallat M., Van der Kooij S., van Kooten C. & de Fijter J. (2016), Fractional Excretion of NGAL Instead of (99m)TcMAG(3) Renography to Monitor Resolution of Delayed Graft Function, American Journal of Transplantation 16: 661-661.
- Moes, D.J.A.R.; Press, R.R.; Ackaert, O.; Ploeger, B.A.; Bemelman, F.J.; Diack, C.; Wessels, J.A.M.; Straaten, T. van der; Danhof, M.; Sanders, J.S.F.; Heide, J.J.H. van der; Guchelaar, H.J. & Fijter, J.W. de (2016), Exploring genetic and non-genetic risk factors for delayed graft function, acute and subclinical rejection in renal transplant recipients, British Journal of Clinical Pharmacology 82(1): 227-237.
- Fijter, J. de; Holdaas, H.; Lopez, P.; Bernhardt, P.; Gaohong, D.; Cruzado, J. & Giet, M. van der (2016), Evaluation According to Donor Source: 24-Month Results from Post-Hoc Analysis of the ELEVATE Study in Kidney Transplant Recipients., American Journal of Transplantation 16: 536-537.
- Kooten, C. van; Pacchiarotta, T.; Pol, P. van der; Fijter, J. de; Schlagwein, N.; Gijlswijk, D. van & Mayboroda, O. (2016), ER Stress and Loss of GRP78 Expression Provides a Link Between Renal Ischemia/Reperfusion Injury and the Urinary Metabolome., American Journal of Transplantation 16: 638-638.
- Dobrowolski, L.C.; Huis, M. van; Lee, J.H. van der; Sengers, H.P.; Lilien, M.R.; Cransberg, K.; Cornelissen, M.; Bouts, A.H.; Fijter, J.W. de; Berger, S.P.; Zuilen, A. van; Nurmohamed, S.A.; Betjes, M.H.G.; Hilbrands, L.; Hoitsma, A.J.; Bemelman, F.J.; Krediet, P. & Groothoff, J.W. (2016), Epidemiology and management of hypertension in paediatric and young adult kidney transplant recipients in The Netherlands, Nephrology Dialysis Transplantation 31(11): 1947-1956.
- Eikmans, M.; Yang, J.; Haasnoot, G.; Kooten, C. van; Mallat, M.; Fijter, H. de; Bajema, I. & Claas, F. (2016), Elevated Intragraft Expression of Innate Immunity and Cell Death-Related Markers Characterizes Deceased Donor Conditions and Is a Risk Factor for Adverse Graft Outcome., American Journal of Transplantation 16: 277-277.
- Yang, J.X.; Haasnoot, G.W.; Kooten, C. van; Mallat, M.J.; Fijter, H.W. de; Bajema, I.M.; Claas, F.H.J. & Eikmans, M. (2016), ELEVATED INTRAGRAFT EXPRESSION OF INNATE IMMUNITY AND CELL DEATH-RELATED MARKERS CHARACTERISES DECEASED DONOR CONDITIONS AND IS A RISK FACTOR FOR ADVERSE GRAFT OUTCOME, Hla 87(4): 207-207.
- Soonawala, D.; Groeneweg, K.; Toorn, F. van der; Heidt, S.; Roelen, D.; Claas, F. & Fijter, J. de (2016), Early Onset Acute Antibody Mediated Rejection (ABMR) Is More Common in Female Than in Male Recipients of a Living Unrelated Donor (LURD) Renal Transplant and Is Associated with the Presence of Preformed Donor Specific Antibodies (DSA)., American Journal of Transplantation 16: 609-610.
- Esmeijer Kevin, Geleijnse Johanna M., Giltay Erik J., Stijnen Theo, Dekker Friedo W., de Fijter Johan W., Kromhout Daan & Hoogeveen Ellen K. (2016), BODY MASS INDEX AND KIDNEY FUNCTION DECLINE IN 60-80 YEARS OLD STATE-OF-THE-ART DRUG-TREATED POST-MYOCARDIAL INFARCTION PATIENTS, Nephrology Dialysis Transplantation 31: 1444-1444.
- Wunderink, H.; Meijden, E. van der; Blij-de Brouwer, C. van der; Mallat, M.; Haasnoot, G.; Zwet, E. van; Claas, E.; Fijter, J. de; Kroes, A.; Arnold, F.; Touze, A.; Claas, F.; Rotmans, J. & Feltkamp, M. (2016), BK Polyomavirus Seroreactivity of Kidney Donors Predicts Viremia and Nephropathy in Recipients., American Journal of Transplantation 16: 356-356.
- Rekers, N.V.; Bajema, I.M.; Mallat, M.J.K.; Petersen, B.; Anholts, J.D.H.; Swings, G.M.J.S.; Miert, P.P.M.C. van; Kerkhoff, C.; Roth, J.; Popp, D.; Groningen, M.C. van; Baeten, D.; Goemaere, N.; Kraaij, M.D.; Zandbergen, M.; Heidt, S.; Kooten, C. van; Fijter, J.W. de; Claas, F.H.J. & Eikmans, M. (2016), Beneficial Immune Effects of Myeloid-Related Proteins in Kidney Transplant Rejection, American Journal of Transplantation 16(5): 1441-1455.
- Kallianidis, A.F.; Ray, A.; Goudkade, D. & Fijter, J.W. de (2016), Amyloid A amyloidosis secondary to hyper IgD syndrome and response to IL-1 blockage therapy, Netherlands Journal of Medicine 74(1): 43-46.
- Kopp, W.H.; Verhagen, M.J.J.; Blok, J.J.; Huurman, V.A.L.; Fijter, J.W. de; Koning, E.J. de; Putter, H.; Baranski, A.G.; Schaapherder, A.F.M.; Braat, A.E. & Ringers, J. (2015), Thirty Years of Pancreas Transplantation at Leiden University Medical Center: Long-term Follow-up in a Large Eurotransplant Center, Transplantation 99(9): E145-E151.
- Bank, J.; Mallat, M.; Boog, P. van der; Braat, D.; Ringers, J.; Vergunst, M.; Heidt, S.; Claas, F.; Reinders, M. & Fijter, J. de (2015), Inadequate Overall Immunosuppression Is a Risk for Late Acute Rejection Despite Alemtuzumab Induction in Simultaneous Pancreas Kidney Transplant Recipients, American Journal of Transplantation 15.
- Massart, A.; Pallier, A.; Guerif, P.; Pascual, J.; Budde, K.; Spasovski, G.; Sever, M.S.; Viklicky, O.; Sorensen, S.S.; Fijter, H. de; Klinger, M.; Hadaya, K.; Dudley, C.; Yussim, A.; Oberbauer, R.; Baron, D.; Maggiore, U.; Giral, M.; Abramowicz, M.; Abramowicz, D. & Brouard, S. (2015), A EUROPE-WIDE SURVEY OF OPERATIONAL TOLERANCE IN KIDNEY TRANSPLANTATION, Transplant International 28: 37-37.
- Fijter, J.W. de; Holdaas, H.; Speziale, A.; Junge, G.; Wang, Z.L.; Cruzado, J.M. & Giet, M. van der (2015), EARLY CONVERSION TO EVEROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS ACHIEVES BETTER RENAL FUNCTION PRESERVATION: 12-MONTH RESULTS FROM THE ELEVATE STUDY, Transplant International 28: 102-102.
- Holdaas Hallvard, Van Der Giet Markus, De Fijter Johan W., Speziale Antonio, Escrig Cesar, Junge Guido, Wang Zailong & Cruzado Josep M. (2015), EFFECT OF EARLY CONVERSION TO EVEROLIMUS ON CARDIOVASCULAR PARAMETERS IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: RESULTS FROM THE ELEVATE STUDY, Transplant International 28: 209-210.
- Fijter, J.W. de; Holdaas, H.; Lopez, P.; Escrig, C.; Wang, Z.L.; Claas, F.H.J.; Arns, W.; Cruzado, J.M. & Giet, M. van der (2015), DE NOVO DONOR SPECIFIC ANTIBODIES AND ASSOCIATION WITH KIDNEY ALLOGRAFT REJECTION AFTER EARLY SWITCH FROM CALCINEURIN INHIBITOR TO EVEROLIMUS: ANALYSIS OF THE ELEVATE TRIAL, Transplant International 28: 130-130.
- Bank, J.; Reinders, M.; Mallat, M.; Schlagwein, N.; Kooij, S. van der; Gijlswijk, D. van; Bajema, I.; Kooten, C. van & Fijter, H. de (2015), Fibrosis, Not Quantitative NGAL-Staining, in Day-10 Protocol Biopsies Predicts Prolonged Duration of Functional Delayed Graft Function in a Cohort of DCD Kidney Transplant Recipients, American Journal of Transplantation 15.
- Van der Giet Markus, Holdaas Hallvard, De Fijter Johan W., Speziale Antonio, Escrig Cesar, Junge Guido, Wang Zailong & Cruzado Josep M. (2015), EFFECT OF EARLY CONVERSION TO EVEROLIMUS VERSUS CONTINUED CNI THERAPY ON LEFT VENTRICULAR HYPERTROPHY IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS, Transplant International 28: 488-488.
- Spithoven, E.M.; Gastel, M.D.A. van; Messchendorp, A.L.; Casteleijn, N.F.; Drenth, J.P.H.; Gaillard, C.A.; Fijter, J.W. de; Meijer, E.; Peters, D.J.M.; Kappert, P.; Renken, R.J.; Visser, F.W.; Wetzels, J.F.M.; Zietse, R.; Gansevoort, R.T. & DIPAK Consortium (2015), Estimation of Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease, American Journal of Kidney Diseases 66(5): 792-801.
- Reinders, M.E.J.; Dreyer, G.J.; Bank, J.R.; Roelofs, H.; Heidt, S.; Roelen, D.L.; Zandvliet, M.L.; Huurman, V.A.L.; Fibbe, W.E.; Kooten, C. van; Claas, F.H.J.; Rabelink, T.J. & Fijter, J.W. de (2015), Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study, Journal of Translational Medicine 13.
- Moes, D.J.A.R.; Guchelaar, H.J. & Fijter, J.W. de (2015), Sirolimus and everolimus in kidney transplantation, Drug Discovery Today 20(10): 1243-1249.
- Kopp, W.; Huurman, V.A.L.; Fijter, J.W. de; Schaapherder, A.F.M.; Ringers, J. & Braat, A.E. (2015), USE OF HIGH PANCREAS DONOR RISK INDEX (PDRI) DONOR GRAFTS LEADS TO INCREASED RISK OF GRAFT THROMBOSIS FOLLOWING PANCREAS TRANSPLANTATION, Transplant International 28: 34-34.
- Dreyer, G.J.; Hemke, A.C.; Reinders, M.E.J. & Fijter, J.W. de (2015), Transplanting the elderly: Balancing aging with histocompatibility, Transplantation Reviews 29(4): 205-211.
- Genders, R.E.; Mazlom, H.; Michel, A.; Plasmeijer, E.I.; Quint, K.D.; Pawlita, M.; Meijden, E. van der; Waterboer, T.; Fijter, H. de; Claas, F.H.; Wolterbeek, R.; Feltkamp, M.C.W. & Bavinck, J.N.B. (2015), The Presence of Betapapillomavirus Antibodies around Transplantation Predicts the Development of Keratinocyte Carcinoma in Organ Transplant Recipients: A Cohort Study, Journal of Investigative Dermatology 135(5): 1275-1282.
- Bank, J.R.; Rabelink, T.J.; Fijter, J.W. de & Reinders, M.E.J. (2015), Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients, Journal of Immunology Research.
- Benck U., Schnuelle P., Habicht A., Renders L., Zeier M., Heller K., Pisarski P., Banas B., Kraemer B. K., Jung M., Lopau K., Olbricht C. -J., Weihprecht H., Schenker P., De Fijter H. W., Yard B. & Schmitt W. H. (2015), EFFECTS OF DOPAMINE DONOR PRETREATMENT ON GRAFT FUNCTION AFTER KIDNEY TRANSPLANTATION: FIVE-YEAR FOLLOW-UP OF A RANDOMIZED CONTROLLED TRIAL, Transplant International 28: 3-3.
- Roelen, D.; Dreyer, G.; Reinders, M.; Brand, S.; Dekkers, O.; Claas, F. & Fijter, H. de (2015), DE NOVO DONOR-SPECIFIC HLA ANTIBODIES AFTER KIDNEY TRANSPLANTATION ARE ASSOCIATED WITH DONATION AFTER CIRCULATORY DEATH AND HLA-DQ MISMATCH, Tissue Antigens 85(5): 406-406.
- Chua, J.S.; Baelde, H.J.; Zandbergen, M.; Wilhelmus, S.; Es, L.A. van; Fijter, J.W. de; Bruijn, J.A.; Bajema, I.M. & Cohen, D. (2015), Complement Factor C4d Is a Common Denominator in Thrombotic Microangiopathy, Journal of the American Society of Nephrology 26(9): 2239-2247.
- Bijkerk, R.; Duijs, J.M.G.J.; Khairoun, M.; Horst, C.J.H. ter; Pol, P. van der; Mallat, M.J.; Rotmans, J.I.; Vries, A.P.J. de; Koning, E.J. de; Fijter, J.W. de; Rabelink, T.J.; Zonneveld, A.J. van & Reinders, M.E.J. (2015), Circulating MicroRNAs Associate With Diabetic Nephropathy and Systemic Microvascular Damage and Normalize After Simultaneous Pancreas-Kidney Transplantation, American Journal of Transplantation 15(4): 1081-1090.
- Wunderink, H.F.; Meijden, E. van der; Blij-de Brouwer, C.S. van der; Touze, A.; Mallat, M.J.; Haasnoot, G.W.; Zwet, E.W. van; Claas, E.C.J.; Fijter, J.W. de; Kroes, A.C.M.; Claas, F.H.J.; Rotmans, J.I. & Feltkamp, M.C.W. (2015), BK-polyomavirus seroreactivity measured in kidney donors is strongly associated with incidence of viremia and nephropathy in their recipients, Journal of Clinical Virology 70: S19-S20.
- Heidt, S.; Vergunst, M.; Anholts, J.D.H.; Reinders, M.E.J.; Fijter, J.W. de; Eikmans, M. & Claas, F.H.J. (2015), B Cell Markers of Operational Tolerance Can Discriminate Acute Kidney Allograft Rejection From Stable Graft Function, Transplantation 99(5): 1058-1064.
- de Fijter J., Holdaas H., Speziale A., Junge G., Wang Z., Cruzado J. & van der Giet M. (2015), Early Conversion to Everolimus in < i > De Novo Kidney Transplant Recipients: 12-Month Results from the ELEVATE Study, American Journal of Transplantation 15.
- Blok, J.; Verhagen, M.; Kopp, W.; Huurman, V.; Fijter, J. de; Koning, E. de; Putter, H.; Ringers, J. & Braat, A. (2014), Differences in Outcome After Pancreas Transplantation: A Plea for a Clearer Definition of Graft Survival, Transplantation 98: 858-858.
- Eikmans, M.; Rekers, N.; Spruyt-Gerritse, M.; Mallat, M.; Zandbergen, M.; Anholts, J.; Bajema, I.; Clahsen-van Groningen, M.; Fijter, J. de; Claas, F. & Heer, E. de (2014), Donor Genotype and Intragraft Expression of CYP3A5 Reflect the Response to Steroid Treatment During Acute Renal Allograft Rejection, Transplantation 98: 261-261.
- Veighy, K.; Clayton, T.; Knight, R.; Robertson, S.; Nicholas, J.; Loukogeorgakis, S.; Fijter, J.W. de; Watson, C.; Harber, M. & MacAllister, R. (2014), Results of the REPAIR Randomised Controlled Trial - Renal Protection Against Ischaemia Reperfusion in Transplantation, Journal of Human Hypertension 28(10): 646-647.
- Otten, H.G.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.; Spierings, E.; Hack, C.E.; Reekum, F. van; Zuilen, A.D. van; Verhaar, M.C.; Bots, M.L.; Seelen, M.A.J.; Sanders, J.S.F.; Hepkema, B.G.; Lambeck, A.J.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Vanderlocht, J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E. van; Gelens, M.; Christiaans, M.; Ittersum, F. van; Nurmohamed, A.; Lardy, N.M.; Swelsen, W.T.; Donselaar-van der Pant, K.A.M.I. van; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.J.; Fijter, J.W. de; Betjes, M.G.H.; Roelen, D.L. & Claas, F.H.J. (2014), The PROCARE consortium: Toward an improved allocation strategy for kidney allografts, Transplant Immunology 31(4): 184-190.
- Bank, J.; Mallat, M.; Boog, P. van der; Braat, A.; Ringers, J.; Reinders, M. & Fijter, J. de (2014), A Steroid-Free Regime With Alemtuzumab Induction Significantly Reduced Acute Rejection Rate in Simultaneous Pancreas Kidney Transplant Recipients., American Journal of Transplantation 14: 855-855.
- Heidt, S.; Vergunst, M.; Anholts, J.D.; Fijter, J.W. de; Eikmans, M. & Claas, F.H.J. (2014), B CELL MARKERS OF OPERATIONAL TOLERANCE CAN DISCRIMINATE ACUTE KIDNEY ALLOGRAFT REJECTION FROM STABLE GRAFT FUNCTION, Tissue Antigens 84(1): 23-23.
- Heidt, S.; Vergunst, M.; Anholts, J.; Fijter, J. de; Eikmans, M. & Claas, F. (2014), B Cell Markers of Operational Tolerance Can Discriminate Acute Kidney Allograft Rejection From Stable Graft Function., American Journal of Transplantation 14: 879-879.
- Eikmans, M.; Rekers, N.; Bajema, I.; Mallat, M.; Anholts, J.; Swings, G.; Miert, P. van; Kerkhoff, C.; Roth, J.; Kooten, C. van; Clahsen-van Groningen, M.; Fijter, J. de & Claas, F. (2014), Beneficial Effects of High S100A9 Expression On Graft Infiltrating Myeloid Cells in Kidney Transplantation., Transplantation 98: 229-229.
- Bijkerk, R.; Duijs, J.; Khairoun, M.; Horst, K. ter; Mallat, M.; Rotmans, J.; Vries, A. de; Koning, E. de; Fijter, H. de; Rabelink, T.; Zonneveld, A. van & Reinders, M. (2014), Circulating MicroRNAs Associate With Pathogenesis of Diabetic Nephropathy and Normalize After Simultaneous Pancreas-Kidney Transplantation., American Journal of Transplantation 14: 526-527.
- Leuning, D.G.; Reinders, M.E.J.; Fijter, J.W. de & Rabelink, T.J. (2014), Clinical Translation of Multipotent Mesenchymal Stromal Cells in Transplantation, Seminars in Nephrology 34(4): 351-364.
- Pol, P. van der; Gijlswijk-Jansen, D. van; Bijkerk, R.; Koning, E. de; Fijter, J. de; Kooten, C. van & Reinders, M. (2014), Elevated MBL Levels in Type 1 Diabetic Patients Are Reversed After Simultaneous Pancreas-Kidney Transplantation, Transplantation 98: 219-219.
- Bredewold, O.W.; Fijter, J.W. de & Rabelink, T. (2014), Cognitive function over time in patients on chronic hemodialysis Reply, Kidney International 85(3): 713-714.
- Kort, H. de; Mallat, M.J.K.; Kooten, C. van; Heer, E. de; Brand-Schaaf, S.H.; Wal, A.M. van der; Roufosse, C.; Roelen, D.L.; Bruijn, J.A.; Claas, F.H.; Fijter, J.W. de & Bajema, I.M. (2014), Diagnosis of Early Pancreas Graft Failure via Antibody-Mediated Rejection: Single-Center Experience With 256 Pancreas Transplantations, American Journal of Transplantation 14(4): 936-942.
- Blok, J.; Verhagen, M.; Kopp, W.; Huurman, V.; Fijter, J. de; Koning, E. de; Putter, H.; Ringers, J. & Braat, A. (2014), Differences in Outcome After Pancreas Transplantation: A Plea for a Clearer Definition of Graft Survival, American Journal of Transplantation 14: 858-858.
- Eikmans, M.; Rekers, N.; Spruyt-Gerritse, M.; Mallat, M.; Zandbergen, M.; Anholts, J.; Bajema, I.; Clahsen-van Groningen, M.; Fijter, J. de; Claas, F. & Heer, E. de (2014), Donor Genotype and Intragraft Expression of CYP3A5 Reflect the Response to Steroid Treatment During Acute Renal Allograft Rejection, American Journal of Transplantation 14: 261-261.
- Rekers, N.V.; Spruyt-Gerritse, M.J.; Mallat, M.J.K.; Zandbergen, M.; Anholts, J.D.; Bajema, I.M.; Clahsen-van Groningen, M.C.; Fijter, H.W. de; Claas, F.H.J. & Eikmans, M. (2014), DONOR GENOTYPE AND INTRAGRAFT EXPRESSION OF CYP3A5 REFLECT THE RESPONSE TO STEROID TREATMENT DURING ACUTE RENAL ALLOGRAFT REJECTION, Tissue Antigens 84(1): 20-20.
- Pol, P. van der; Gijlswijk-Jansen, D. van; Bijkerk, R.; Koning, E. de; Fijter, J. de; Kooten, C. van & Reinders, M. (2014), Elevated MBL Levels in Type 1 Diabetic Patients Are Reversed After Simultaneous Pancreas-Kidney Transplantation., American Journal of Transplantation 14: 219-219.
- Chen, Z.G.; Bouamar, R.; Schaik, R.H.N. van; Fijter, J.W. de; Hartmann, A.; Zeier, M.; Budde, K.; Kuypers, D.R.J.; Weimar, W.; Hesselink, D.A. & Gelder, T. van (2014), Genetic polymorphisms in IL-2, IL-10, TGF-beta 1, and IL-2RB and acute rejection in renal transplant patients, Clinical Transplantation 28(6): 649-655.
- Eikmans, M.; Anholts, J.; Heidt, S.; Fijter, J. de & Claas, F. (2014), Identification of Urinary MicroRNAs That Are Discriminative of Acute Rejection in Kidney Transplantation., American Journal of Transplantation 14: 903-903.
- Elens, L.; Hesselink, D.A.; Bouamar, R.; Budde, K.; Fijter, J.W. de; Meyer, K. de; Mourad, M.; Kuypers, D.R.J.; Haufroid, V.; Gelder, T. van & Schaik, R.H.N. van (2014), Impact of POR*28 on the Pharmacokinetics of Tacrolimus and Cyclosporine A in Renal Transplant Patients, Therapeutic Drug Monitoring 36(1): 71-79.
- Reinders, M.E.J.; Fijter, J.W. de & Rabelink, T.J. (2014), Mesenchymal stromal cells to prevent fibrosis in kidney transplantation, Current Opinion in Organ Transplantation 19(1): 54-59.
- Baas, M.C.; Struijk, G.H.; Moes, D.J.A.R.; Berk, I.A.H. van den; Jonkers, R.E.; Fijter, J.W. de; Heide, J.J.H. van der; Dijk, M. van; Berge, I.J.M. ten & Bemelman, F.J. (2014), Interstitial pneumonitis caused by everolimus: a case-cohort study in renal transplant recipients, Transplant International 27(5): 428-436.
- Reindersa, M.E.J.; Leuning, D.G.; Fijter, J.W. de; Hoogduijn, M.J. & Rabelink, T.J. (2014), Mesenchymal Stromal Cell Therapy for Cardio Renal Disorders, Current Pharmaceutical Design 20(14): 2412-2429.
- Blok, J.J.; Fijter, J.W. de; Braat, A.E.; Verhagen, M.J. & Ringers, J. (2014), Old-to-old pancreas transplantation, what is old in the USA may be young in Europe, Transplant International 27(4): E31-E32.
- Meijer, E.; Drenth, J.P.H.; d'Agnolo, H.; Casteleijn, N.F.; Fijter, J.W. de; Gevers, T.J.; Kappert, P.; Peters, D.J.M.; Salih, M.; Soonawala, D.; Spithoven, E.M.; Torres, V.E.; Visser, F.W.; Wetzels, J.F.M.; Zietse, R.; Gansevoort, R.T. & DIPAK Consortium (2014), Rationale and Design of the DIPAK 1 Study: A Randomized Controlled Clinical Trial Assessing the Efficacy of Lanreotide to Halt Disease Progression in Autosomal Dominant Polycystic Kidney Disease, American Journal of Kidney Diseases 63(3): 446-455.
- Navis, G.J.; Blankestijn, P.J.; Deegens, J.; Fijter, J.W. de; Heide, J.J.H. van der; Rabelink, T.; Krediet, R.T.; Kwakernaak, A.J.; Laverman, G.D.; Leunissen, K.M.; Paassen, P. van; Vervloet, M.G.; Wee, P.M. ter; Wetzels, J.F.; Zietse, R.; Ittersum, F.J. van & BIND-NL Investigators (2014), The Biobank of Nephrological Diseases in the Netherlands cohort: the String of Pearls Initiative collaboration on chronic kidney disease in the university medical centers in the Netherlands, Nephrology Dialysis Transplantation 29(6): 1145-1150.
- Reindersa, M.E.J.; Leuning, D.G.; Fijter, J.W. de; Hoogduijn, M.J. & Rabelink, T.J. (2014), Mesenchymal Stromal Cell Therapy for Cardio Renal Disorders, Current Pharmaceutical Design 20(14): 2412-2429.
- Reinders, M.E.J.; Fijter, J.W. de & Rabelink, T.J. (2014), Mesenchymal stromal cells to prevent fibrosis in kidney transplantation, Current Opinion in Organ Transplantation 19(1): 54-59.
- Eikmans, M.; Rekers, N.; Bajema, I.; Mallat, M.; Anholts, J.; Swings, G.; Miert, P. van; Kerkhoff, C.; Roth, J.; Kooten, C. van; Clahsen-van Groningen, M.; Fijter, J. de & Claas, F. (2014), Beneficial Effects of High S100A9 Expression On Graft Infiltrating Myeloid Cells in Kidney Transplantation, American Journal of Transplantation 14: 229-229.
- Lantinga M. A., Gevers T. J. G., de Sevaux R. G. L., Oyen W. J. G., de Fijter J. W., Soonawala D., Salih M., Meijer E., Gansevoort R. T. & Drenth J. P. H. (2014), CHARACTERIZATION AND MANAGEMENT OF HEPATIC AND RENAL CYST INFECTION PATIENTS - A MULTICENTER RETROSPECTIVE STUDY, Journal of Hepatology 60(1): S506-S506.
- Bank, J.; Mallat, M.; Boog, P. van der; Braat, A.; Ringers, J.; Reinders, M. & Fijter, J. de (2014), A Steroid-Free Regime With Alemtuzumab Induction Significantly Reduced Acute Rejection Rate in Simultaneous Pancreas Kidney Transplant Recipients., Transplantation 98: 855-855.
- Reinders, M.E.J.; Bank, J.R.; Dreyer, G.J.; Roelofs, H.; Heidt, S.; Roelen, D.L.; Huurman, V.A.L.; Lindeman, J.; Kooten, C. van; Claas, F.H.J.; Fibbe, W.E.; Rabelink, T.J. & Fijter, J.W. de (2014), Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients, Journal of Translational Medicine 12.
- Heidt, S.; Vergunst, M.; Anholts, J.; Fijter, J. de; Eikmans, M. & Claas, F. (2014), B Cell Markers of Operational Tolerance Can Discriminate Acute Kidney Allograft Rejection From Stable Graft Function., Transplantation 98: 879-879.
- Bijkerk, R.; Duijs, J.; Khairoun, M.; Horst, K. ter; Mallat, M.; Rotmans, J.; Vries, A. de; Koning, E. de; Fijter, H. de; Rabelink, T.; Zonneveld, A. van & Reinders, M. (2014), Circulating MicroRNAs Associate With Pathogenesis of Diabetic Nephropathy and Normalize After Simultaneous Pancreas-Kidney Transplantation, Transplantation 98: 526-527.
- Daleboudt, G.M.N.; Reinders, M.E.J.; Hartigh, J. den; Huizinga, T.W.J.; Rabelink, A.J.; Fijter, J.W. de & Berger, S.P. (2013), Concentration-controlled treatment of lupus nephritis with mycophenolate mofetil, Lupus 22(2): 171-179.
- Rekers, N.V.; Bajema, I.M.; Mallat, M.J.K.; Anholts, J.D.H.; Vaal, Y.J.H. de; Zandbergen, M.; Haasnoot, G.W.; Zwet, E.W. van; Fijter, J.W. de; Claas, F.H.J. & Eikmans, M. (2013), Increased Metallothionein Expression Reflects Steroid Resistance in Renal Allograft Recipients, American Journal of Transplantation 13(8): 2106-2118.
- Khairoun, M.; Ocak, G.; Rotmans, J.; Vries, A. de; Berg, B. van den; Lievers, E.; Mallat, M.; Vries, D. de; Zonneveld, A. van; Fijter, J. de; Rabelink, T. & Reinders, M. (2013), Acute Rejection Is Associated with Increased Microvascular Tortuosity and a Dysbalance in Angiopoietins up to 1 Year after Rejection., American Journal of Transplantation 13: 502-502.
- Reinders, M.; Fijter, J. de; Roelofs, H.; Vries, D. de; Claas, F.; Miert, P. van; Roelen, D.; Kooten, C. van & Rabelink, T. (2013), Treatment of Renal Transplant Patients with Autologous Bone Marrow Derived Mesenchymal Stromal Cells Downregulates the Donor Specific Mixed Lymphocyte Reaction., American Journal of Transplantation 13: 340-340.
- Reinders, M.E.J.; Rabelink, T.J. & Fijter, J.W. de (2013), The role of mesenchymal stromal cells in chronic transplant rejection after solid organ transplantation, Current Opinion in Organ Transplantation 18(1): 44-50.
- Mourer, J.S.; Koning, E.J.P. de; Zwet, E.W. van; Mallat, M.J.K.; Rabelink, T.J. & Fijter, J.W. de (2013), Impact of Late Calcineurin Inhibitor Withdrawal on Ambulatory Blood Pressure and Carotid Intima Media Thickness in Renal Transplant Recipients, Transplantation 96(1): 49-57.
- Blok, J.J.; Ringers, J.; Schaapherder, A.F.; Dubbeld, J.; Baranski, A.G.; Fijter, J.W. de; Boog, P.J. van der; Verhagen, M.J. & Braat, A.E. (2013), Report of the first five DCDD pancreas transplants within the Eurotransplant region; excellent results with prolonged first warm ischemia times, Transplant International 26(4): e31-e33.
- Khairoun, M.; Koning, E.J.P. de; Berg, B.M. van den; Lievers, E.; Boer, H.C. de; Schaapherder, A.F.M.; Mallat, M.J.K.; Rotmans, J.I.; Boog, P.J.M. van der; Zonneveld, A.J. van; Fijter, J.W. de; Rabelink, T.J. & Reinders, M.E.J. (2013), Microvascular Damage in Type 1 Diabetic Patients Is Reversed in the First Year After Simultaneous Pancreas-Kidney Transplantation, American Journal of Transplantation 13(5): 1272-1281.
- Eikmans, M.; Anholts, J.D.H.; Heidt, S.; Fijter, H.W. de & Claas, F.H.J. (2013), MICRO-RNA PROFILING IN URINARY SEDIMENT OF TRANSPLANT RECIPIENTS WITH ACUTE REJECTION, Tissue Antigens 81(5): 281-282.
- Ringers, J.; Torren, C.R. van der; Linde, P. van de; Boog, P.J.M. van der; Mallat, M.J.K.; Bonifacio, E.; Roep, B.O. & Fijter, J.W. de (2013), Pretransplantation GAD-Autoantibody Status to Guide Prophylactic Antibody Induction Therapy in Simultaneous Pancreas and Kidney Transplantation, Transplantation 96(8): 745-752.
- Fijter, J.W. de & Bavinck, J.N.B. (2013), Sirolimus Reduces Cutaneous Squamous Cell Carcinomas in Transplantation Recipients Reply, Journal of Clinical Oncology 31(26): 3298-3298.
- Hoogendijk-van den Akker, J.M.; Harden, P.N.; Hoitsma, A.J.; Proby, C.M.; Wolterbeek, R.; Bavinck, J.N.B. & Fijter, J.W. de (2013), Two-Year Randomized Controlled Prospective Trial Converting Treatment of Stable Renal Transplant Recipients With Cutaneous Invasive Squamous Cell Carcinomas to Sirolimus, Journal of Clinical Oncology 31(10): 1317-1323.
- Netelenbos, T.; Bouwsma, H.; Noort, F.A.; Groot, I. de; Fijter, J.W. de & Zwaginga, J.J. (2013), Immune adsorption of anti-A/B antibodies prior to ABO-mismatched kidney transplantation: The Leiden experience, Transfusion and Apheresis Science 48(2): 185-185.
- Eikmans, M.; Anholts, J.D.H.; Heidt, S.; Fijter, J.W. de & Claas, F.H.J. (2013), IDENTIFICATION OF URINARY MICRORNAS THAT ARE DISCRIMINATIVE OF ACUTE REJECTION IN KIDNEY TRANSPLANTATION., Human Immunology 74: 29-29.
- Khairoun, M.; Ocak, G.; Rotmans, J.; Vries, A. de; Berg, B. van den; Lievers, E.; Mallat, M.; Vries, D. de; Zonneveld, A. van; Fijter, J. de; Rabelink, T. & Reinders, M. (2013), Acute Rejection Is Associated with Increased Microvascular Tortuosity and a Dysbalance in Angiopoietins up to 1 Year after Rejection., American Journal of Transplantation 13: 502-502.
- Rekers, N.V.; Bajema, I.M.; Mallat, M.; Anholts, J.D.H.; Kerkhoff, C.; Roth, J.; Swings, G.M.J.S.; Groningen, M.C. van; Fijter, H.W. de; Claas, F.H.J. & Eikmans, M. (2013), HIGH EXPRESSION OF S100 CALCIUM BINDING PROTEINS A8 AND A9 IN MACROPHAGES DURING ACUTE TRANSPLANT REJECTION IS ASSOCIATED WITH A BENEFICIAL IMMUNE RESPONSE, Tissue Antigens 81(5): 279-280.
- Rekers, N.; Bajema, I.; Mallat, M.; Anholts, J.; Kerkhoff, C.; Roth, J.; Swings, G.; Groningen, M.; Fijter, H.W. de; Claas, F. & Eikmans, M. (2013), HIGH EXPRESSION OF S100 CALCIUM BINDING PROTEINS A8 AND A9 IN MACROPHAGES DURING ACUTE TRANSPLANT REJECTION IS ASSOCIATED WITH A BENEFICIAL IMMUNE RESPONSE, Transplant International 26: 122-123.
- Heidt, S.; Vergunst, M.; Anholts, J.D.H.; Eikmans, M.; Fijter, H.W. de & Claas, F.I.J. (2013), EVIDENCE FOR A POSSIBLE ROLE OF MEMORY B CELLS IN ACUTE KIDNEY GRAFT REJECTION, Human Immunology 74: 47-47.
- Moes, D.J.A.R.; Swen, J.J.; Hartigh, J. den; Straaten, T. van der; Heide, J.J.H. van der; Bemelman, F.; Fijter, J.W. de & Guchelaar, H.J. (2013), Evaluating the Effect of CYP3A4 and CYP3A5 Polymorphisms on Cyclosporine, Everolimus and Tacrolimus Pharmacokinetics in Renal Transplantation Patients, Therapeutic Drug Monitoring 35(5): 672-672.
- Baas, M.C.; Kers, J.; Florquin, S.; Fijter, J.W. de; Heide, J.J.H. van der; Weerman, M.A.V.; Berge, I.J.M. ten & Bemelman, F.J. (2013), Cyclosporine versus everolimus: effects on the glomerulus, Clinical Transplantation 27(4): 535-540.
- Heidt, S.; Schenk, V.; Eikmans, M.; Fijter, H.W. de & Claas, F.H.J. (2013), CXCL9 AND CXCL 10 LEVELS IN URINE ARE SUITABLE PARAMETERS FOR DIAGNOSIS AND PREDICTION OF ACUTE REJECTION, Tissue Antigens 81(5): 266-267.
- Heidt, S.; Schenk, V.; Eikmans, M.; Fijter, H.W. de & Claas, F. (2013), CXCL9 AND CXCL 10 LEVELS IN URINE ARE SUITABLE PARAMETERS FOR DIAGNOSIS AND PREDICTION OF ACUTE REJECTION, Transplant International 26: 135-135.
- Bijkerk, R.; Khairoun, M.; Duijs, J.; Horst, K. ter; Vries, A. de; Koning, E. de; Fijter, J. de; Rabelink, T.; Zonneveld, A. van & Reinders, M. (2013), Circulating MicroRNAs Correlate with Diabetic Nephropathy and Systemic Microvascular Damage and Normalize after Simultaneous Pancreas-Kidney Transplantation., American Journal of Transplantation 13: 440-440.
- Reinders, M.E.J.; Roemeling-van Rhijn, M.; Khairoun, M.; Lievers, E.; Vries, D.K. de; Schaapherder, A.F.M.; Wong, S.W.S.; Zwaginga, J.J.; Duijs, J.M.; Zonneveld, A.J. van; Hoogduijn, M.J.; Fibbe, W.E.; Fijter, J.W. de; Kooten, C. van; Rabelink, T.J. & Roelofs, H. (2013), Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy, Cytotherapy 15(6): 663-672.
- Reinders, M.E.J.; Fijter, J.W. de; Roelofs, H.; Bajema, I.M.; Vries, D.K. de; Schaapherder, A.F.; Claas, F.H.J.; Miert, P.P.M.C. van; Roelen, D.L.; Kooten, C. van; Fibbe, W.E. & Rabelink, T.J. (2013), Autologous Bone Marrow-Derived Mesenchymal Stromal Cells for the Treatment of Allograft Rejection After Renal Transplantation: Results of a Phase I Study, Stem Cells Translational Medicine 2(2): 107-111.
- Adema, A.Y.; Dorp, W.T.H. van; Mallat, M.J.K. & Fijter, H. de (2013), PROGNOSTIC FACTORS FOR THE LIFE EXPECTANCY OF PATIENTS AT THE MOMENT OF KIDNEY TRANSPLANTATION, Nephrology Dialysis Transplantation 28: 290-290.
- Doesum, W. van; Gard, L.; Son, W.J. van; Sanders, J.S.F.; Riezebos, A.; Niesters, B.G.M.; Bemelman, F.J. & Fijter, H.W. de (2013), INCIDENCE AND OUTCOME OF BK INFECTION IN A RANDOMIZED CONTROLLED MULTICENTER STUDY WITH RENAL TRANSPLANT PATIENTS RECEIVING DUO-THERAPY, Transplant International 26: 166-166.
- Elens, L.; Hesselink, D.A.; Bouamar, R.; Budde, K.; Fijter, J.W. de; Kuypers, D.R.J.; Haufroid, V.; Gelder, T. van & Schaik, R.H.N. van (2013), Impact of POR*28 on the Pharmacokinetics of Tacrolimus and Cyclosporine A in Renal Transplant Patients, Therapeutic Drug Monitoring 35(5): 709-709.
- Eikmans, M.; Canck, I. de; Pol, P. van der; Baan, C.C.; Haasnoot, G.W.; Mallat, M.J.K.; Vergunst, M.; Meester, E. de; Roodnat, J.I.; Anholts, J.D.H.; Thielen, M. van; Doxiadis, I.I.N.; Fijter, J.W. de; Linden, P.J.E. van der; Beelen, E. van; Kooten, C. van; Kal-van Gestel, J.A.; Peeters, A.M.A.; Weimar, W.; Roelen, D.L.; Rossau, R. & Claas, F.H.J. (2012), The Functional Polymorphism Ala258Ser in the Innate Receptor Gene Ficolin-2 in the Donor Predicts Improved Renal Transplant Outcome, Transplantation 94(5): 478-485.
- Pol, P. van der; Vries, D.K. de; Gijlswijk, D.J. van; Anken, G.E. van; Schlagwein, N.; Daha, M.R.; Aydin, Z.; Fijter, J.W. de; Schaapherder, A.F.M. & Kooten, C. van (2012), Pitfalls in urinary complement measurements, Transplant Immunology 27(1): 55-58.
- Aydin, Z.; Mallat, M.J.K.; Schaapherder, A.F.M.; Zonneveld, A.J. van; Kooten, C. van; Rabelink, T.J. & Fijter, J.W. de (2012), Randomized Trial of Short-Course High-Dose Erythropoietin in Donation After Cardiac Death Kidney Transplant Recipients, American Journal of Transplantation 12(7): 1793-1800.
- Rekers, N.V.; Bajema, I.M.; Mallat, M.J.K.; Zuidwijk, K.; Anholts, J.D.H.; Goemaere, N.; Haasnoot, G.W.; Groningen, M.C. van; Kooten, C. van; Fijter, J.W. de; Claas, F.H.J. & Eikmans, M. (2012), Quantitative Polymerase Chain Reaction Profiling of Immunomarkers in Rejecting Kidney Allografts for Predicting Response to Steroid Treatment, Transplantation 94(6): 596-602.
- Mourer, J.S.; Hartigh, J. den; Zwet, E.W. van; Mallat, M.J.K.; Dubbeld, J. & Fijter, J.W. de (2012), Randomized Trial Comparing Late Concentration-Controlled Calcineurin Inhibitor or Mycophenolate Mofetil Withdrawal, Transplantation 93(9): 887-894.
- Moes, D.J.A.R.; Press, R.R.; Hartigh, J. den; Straaten, T. van der; Fijter, J.W. de & Guchelaar, H.J. (2012), Population Pharmacokinetics and Pharmacogenetics of Everolimus in Renal Transplant Patients, Clinical Pharmacokinetics 51(7): 467-480.
- Bouamar, R.; Hesselink, D.A.; Schaik, R.H.N. van; Weimar, W.; Heiden, I.P. van der; Fijter, J.W. de; Kuypers, D.R.J. & Gelder, T. van (2012), Mycophenolic acid-related diarrhea is not associated with polymorphisms in SLCO1B nor with ABCB1 in renal transplant recipients, Pharmacogenetics and Genomics 22(6): 399-407.
- Mourer, J.S.; Ewe, S.H.; Mallat, M.J.K.; Ng, A.C.T.; Rabelink, T.J.; Bax, J.J.; Delgado, V. & Fijter, J.W. de (2012), Late Calcineurin Inhibitor Withdrawal Prevents Progressive Left Ventricular Diastolic Dysfunction in Renal Transplant Recipients, Transplantation 94(7): 721-728.
- Zuidwijk, K.; Fijter, J.W. de; Mallat, M.J.K.; Eikmans, M.; Groningen, M.C. van; Goemaere, N.N.; Bajema, I.M. & Kooten, C. van (2012), Increased influx of myeloid dendritic cells during acute rejection is associated with interstitial fibrosis and tubular atrophy and predicts poor outcome, Kidney International 81(1): 64-75.
- Blok, J.J.; Braat, A.E.; Schaapherder, A.F.; Verhagen, M.J.; Fijter, J.W. de; Putter, H.; Rahmel, A.O. & Ringers, J. (2012), The P-PASS and PDRI Reviewed in a Large European Pancreas Transplantation Center; Preliminary Results, American Journal of Transplantation 12: 261-261.
- Fijter, J.W. de; Hoogendijk-Van den Akker, J.M.; Harden, P.N.; Hoitsma, A.J.; Proby, C.; Wolterbeek, R. & Bavinck, J.N.B. (2012), Reduced Cutaneous Squamous Cell Carcinoma after Conversion to Sirolimus: A 2-Year Prospective Open-Label Multicenter Trial, American Journal of Transplantation 12: 161-161.
- Eikmans, M.; Canck, I. de; Pol, P. van der; Baan, C.C.; Haasnoot, G.W.; Mallat, M.J.K.; Vergunst, M.; Meester, E. de; Roodnat, J.I.; Anholts, J.D.H.; Thielen, M. van; Doxiadis, I.I.N.; Fijter, H.W. de; Linden, C.J.E. van der; Beelen, E. van; Kooten, C. van; Kal-van Gestel, J.; Peeters, A.M.A.; Weimar, W.; Roelen, D.L.; Rossau, R. & Claas, F.H.J. (2012), The Functional Polymorphism Ala258Ser in Ficolin-2 in the Donor Kidney Predicts Improved Renal Transplant Outcome, American Journal of Transplantation 12: 312-312.
- Rekers, N.V.; Anholts, J.D.H.; Haasnoot, G.W.; Mallat, M.J.K.; Bajema, I.M.; Fijter, J.W. de; Claas, F.H.J. & Eikmans, M. (2012), Intragraft Expression of Metallothioneins in Kidney Transplant Patients May Be a Novel Marker of Response to Anti-Rejection Treatment with Corticosteroids, American Journal of Transplantation 12: 456-457.
- Khairoun, M.; Berg, B.M. van den; Timal, R.; Lievers, E.; Schaapherder, A.F.; Zonneveld, A.J. van; Fijter, J.W. de; Rabelink, T.J. & Reinders, M.E.J. (2012), Improvement of Microvascular Damage after Living Donor Kidney-Transplantation, American Journal of Transplantation 12: 504-504.
- Wisgerhof, H.C.; Wolterbeek, R.; Haasnoot, G.W.; Claas, F.H.J.; Fijter, J.W. de; Willemze, R. & Bavinck, J.N.B. (2012), The risk of cancer is not increased in patients with multiple kidney transplantations., Transplant Immunology 27(4): 189-94.
- Pol, P. van der; Schlagwein, N.; Gijlswijk, D.J. van; Berger, S.P.; Roos, A.; Bajema, I.M.; Boer, H.C. de; Fijter, J.W. de; Stahl, G.L.; Daha, M.R. & Kooten, C. van (2012), Mannan-Binding Lectin Mediates Renal Ischemia/Reperfusion Injury Independent of Complement Activation, American Journal of Transplantation 12(4): 877-887.
- Wisgerhof, H.C.; Wolterbeek, R.; Fijter, J.W. de; Willemze, R. & Bavinck, J.N.B. (2012), Kidney transplant recipients with cutaneous squamous cell carcinoma have an increased risk of internal malignancy.
- Botermans, J.M.; Kort, H. de; Eikmans, M.; Koop, K.; Baelde, H.J.; Mallat, M.J.K.; Zuidwijk, K.; Kooten, C. van; Heer, E. de; Goemaere, N.N.T.; Claas, F.H.J.; Bruijn, J.A.; Fijter, J.W. de; Bajema, I.M. & Groningen, M.C. van (2011), C4d Staining In Renal Allograft Biopsies with Early Acute Rejection and Subsequent Clinical Outcome, Clinical Journal of the American Society of Nephrology 6(5): 1207-1213.
- Eikmans, M.; Canck, I. de; Pol, P. van der; Baan, C.C.; Haasnoot, G.W.; Mallat, M.J.K.; Bryson-Vergunst, M.; Meester, E. de; Roodnat, J.I.; Anholts, J.D.H.; Thielen, M. van; Doxiadis, I.I.N.; Fijter, H.W. de; Linden, P.J.E. van der; Beelen, E. van; Kooten, C. van; Kal-van Gestel, J.A.; Peeters, A.M.A.; Weimar, W.; Roelen, D.L.; Rossau, R. & Claas, F.H.J. (2011), A FUNCTIONAL POLYMORPHISM IN FICOLIN-2 IN THE DONOR KIDNEY IS ASSOCIATED WITH IMPROVED RENAL TRANSPLANT OUTCOME., Human Immunology 72: S191-S191.
- Eikmans, M.; Canck, I. de; Pol, P. van der; Baan, C.C.; Haasnoot, G.W.; Mallat, M.J.K.; Bryson-Vergunst, M.; Meester, E. de; Roodnat, J.I.; Anholts, J.D.H.; Thielen, M. van; Doxiadis, I.I.N.; Fijter, H.W. de; Linden, P.J.E. van der; Beelen, E. van; Kooten, C. van; Kal-van Gestel, J.; Peeters, A.M.A.; Weimar, W.; Roelen, D.L.; Rossau, R. & Claas, F.H.J. (2011), A functional polymorphism in Ficolin-2 in the donor kidney is associated with improved renal transplant outcome, Tissue Antigens 77(5): 384-384.
- Fijter, J.W. de (2011), Counselling the elderly between hope and reality.
- Giet, M. van der; Fijter, J.W. de; Holdaas, H.; Legendre, C.; Machein, U.; Junge, G. & Cruzado, J.M. (2011), EFFECT OF EARLY CONVERSION FROM CALCINEURIN INHIBITORS TO EVEROLIMUS ON RENAL FUNCTION AND MARKERS OF CARDIOVASCULAR DISEASE: DESIGN OF THE ELEVATE STUDY.
- Campistol, J.M.; Fijter, J.W. de; Nashan, B.; Holdaas, H.; Vitko, S. & Legendre, C. (2011), Everolimus and Long-Term Outcomes in Renal Transplantation, Transplantation 92(3): S3-S26.
- Bergen, J. van; Thompson, A.; Haasnoot, G.W.; Roodnat, J.I.; Fijter, J.W. de; Claas, F.H.J.; Koning, F. & Doxiadis, I.I.N. (2011), KIR-Ligand Mismatches Are Associated With Reduced Long-Term Graft Survival in HLA-Compatible Kidney Transplantation, American Journal of Transplantation 11(9): 1959-1964.
- Bergen, J. van; Thompson, A.; Haasnoot, G.W.; Roodnat, J.J.; Fijter, J.W. de; Claas, F.H.J.; Koning, F. & Doxiadis, I.I.N. (2011), KIR-LIGAND MISMATCHES ARE ASSOCIATED WITH REDUCED LONG-TERM GRAFT SURVIVAL IN HLA FULLY COMPATIBLE KIDNEY TRANSPLANTATION., Human Immunology 72: S192-S192.
- Aydin, Z.; Dubbeld, J.; Mallat, M.J.; Ringers, J.; Rabelink, T.J. & Fijter, J.W. de (2011), PROSPECTIVE TRIAL ON ERYTHROPOIETIN IN CLINICAL TRANSPLANTATION.
- Boer, M.G.J. de; Kroon, F.P.; Cessie, S. le; Fijter, J.W. de & Dissel, J.T. van (2011), Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis.
- Fijter, J.W. de; Ewe, S.H.; Hartigh, J. den; Ng, A.C.T.; Delgado, V.; Mallat, M.J.K.; Bax, J.J.; Ringers, J.; Rabelink, T.J. & Mourer, J.S. (2011), Beneficial Effects of Late Concentratiqon-Controlled CNI Withdrawal in Renal Transplant Recipients., American Journal of Transplantation 11: 406-406.
- Brand-Schaaf, S.H.; Roelen, D.L.; Doxiadis, I.I.N.; Stein, S.; Fijter, J.W. de & Claas, F.H.J. (2011), Case study: proving old concepts and providing new insights, Tissue Antigens 77(5): 445-445.
- Hoogeveen, E.K.; Aalten, J.; Rothman, K.J.; Roodnat, J.I.; Mallat, M.J.K.; Borm, G.; Weimar, W.; Hoitsma, A.J. & Fijter, J.W. de (2011), Effect of Obesity on the Outcome of Kidney Transplantation: A 20-Year Follow-Up, Transplantation 91(8): 869-874.
- Gelder, T. van; Silva, H.T.; Fijter, H. de; Budde, K.; Kuypers, D.; Mamelok, R.D.; Armstrong, V.W. & Oellerich, M. (2011), How Delayed Graft Function Impacts Exposure to Mycophenolic Acid in Patients After Renal Transplantation, Therapeutic Drug Monitoring 33(2): 155-164.
- Bouamar, R.; Hesselink, D.A.; Schaik, R.H.N. van; Weimar, W.; MacPhee, I.A.M.; Fijter, J.W. de & Gelder, T. van (2011), Polymorphisms in CYP3A5, CYP3A4, and ABCB1 are Not Associated With Cyclosporine Pharmacokinetics Nor With Cyclosporine Clinical End Points After Renal Transplantation, Therapeutic Drug Monitoring 33(2): 178-184.
- Fijter, J.W. de (2011), Tacrolimus Dosing in Mycophenolate-Treated Patients-Can We Get Away With Less?, Transplantation 92(1): 10-11.
- Aydin, Z.; Dubbeld, J.; Mallat, M.J.; Ringers, J.; Rabelink, T.J. & Fijter, J.W. de (2011), PROspective Trial on Erythropoietin in Clinical Transplantation., American Journal of Transplantation 11: 36-37.
- Boer, M.G.J. de; Fijter, J.W. de & Kroon, F.P. (2011), Outbreaks and clustering of Pneumocystis pneumonia in kidney transplant recipients: a systematic review, Medical Mycology 49(7): 673-680.
- Wisgerhof, H.C.; Geest, L.G.M. van der; Fijter, J.W. de; Haasnoot, G.W.; Claas, F.H.J.; Cessie, S. le; Willemze, R. & Bavinck, J.N.B. (2011), Incidence of cancer in kidney-transplant recipients: A long-term cohort study in a single center, Cancer Epidemiology 35(2): 105-111.
- Wisgerhof, H.C.; Edelbroek, J.R.J.; Fijter, J.W. de; Haasnoot, G.W.; Claas, F.H.J.; Willemze, R. & Bavinck, J.N.B. (2010), Subsequent Squamous- and Basal-Cell Carcinomas in Kidney-Transplant Recipients After the First Skin Cancer: Cumulative Incidence and Risk Factors, Transplantation 89(10): 1231-1238.
- Gruijl, F.R. de; Koehl, G.E.; Voskamp, P.; Strik, A.; Rebel, H.G.; Gaumann, A.; Fijter, J.W. de; Tensen, C.P.; Bavinck, J.N.B. & Geissler, E.K. (2010), Early and late effects of the immunosuppressants rapamycin and mycophenolate mofetil on UV carcinogenesis, International Journal of Cancer 127(4): 796-804.
- Gelder, T. van; Silva, H.T.; Fijter, J.W. de; Budde, K.; Kuypers, D.; Arns, W.; Soulillou, J.P.; Kanellis, J.; Zelvys, A.; Ekberg, H.; Holzer, H.; Rostaing, L. & Mamelok, R.D. (2010), Renal Transplant Patients at High Risk of Acute Rejection Benefit From Adequate Exposure to Mycophenolic Acid, Transplantation 89(5): 595-599.
- Campistol, J.M.; Fijter, J.W. de; Flechner, S.M.; Langone, A.; Morelon, E. & Stockfleth, E. (2010), mTOR inhibitor-associated dermatologic and mucosal problems, Clinical Transplantation 24(2): 149-156.
- Dekter, H.E.; Romijn, F.P.H.T.M.; Temmink, W.P.M.; Pelt, J. van; Fijter, J.W. de & Smit, N.P.M. (2010), A spectrophotometric assay for routine measurement of mammalian target of rapamycin activity in cell lysates, Analytical Biochemistry 403(1-2): 79-87.
- Rekers, N.V.; Bajema, I.M.; Mallat, M.; Zuidwijk, K.; Anholts, J.D.H.; Goemaere, N.; Groningen, M.C. van; Kooten, C. van; Fijter, J.W. de; Claas, F.H.J. & Eikmans, M. (2010), Quantitative PCR profiling of kidney transplant patients for prediction of response to anti-rejection treatment with steroids, Tissue Antigens 75(5): 595-595.
- Eikmans, M.; Waanders, M.M.; Roelen, D.L.; Miert, P.P.M.C. van; Anholts, J.D.H.; Fijter, H.W. de; Brand, A. & Claas, F.H.J. (2010), Differential effect of pre-transplant blood transfusions on immune effector and regulatory mechanisms in individuals with and without previous HLA alloantigen exposure, Tissue Antigens 75(5): 485-486.
- Fijter, J.W. de (2010), Kidney allocation: where utility and fairness meet.
- Fijter, J.W. de (2010), Rejection and function and chronic allograft dysfunction, Kidney International 78: S38-S41.
- Press, R.R.; Fijter, J.W. de & Guchelaar, H.J. (2010), Individualizing Calcineurin Inhibitor Therapy in Renal Transplantation - Current Limitations and Perspectives, Current Pharmaceutical Design 16(2): 176-186.
- Doxiadis, I.I.N.; Thompson, A.; Haasnot, G.W.; Roodnat, J.I.; Fijter, J.W. de; Claas, F.H.J.; Koning, F. & Bergen, J. van (2010), EVIDENCE FOR NATURAL KILLER CELL INDUCED GRAFT LOSS IN HLA FULL COMPATIBLE KIDNEY TRANSPLANTATION., Human Immunology 71: S139S139.
- Eikmans, M.; Waanders, M.M.; Roelen, D.L.; Miert, P.P.M.C. van; Anholts, J.D.H.; Fijter, J.W. de; Brand, A. & Claas, F.H.J. (2010), DIFFERENTIAL EFFECT OF PRE-TRANSPLANT BLOOD TRANSFUSIONS ON IMMUNE EFFECTOR AND REGULATORY COMPARTMENTS IN HLA-SENSITIZED- AND NON-SENSITIZED RECIPIENTS., Human Immunology 71: S152S152.
- Eikmans, M.; Waanders, M.M.; Roelen, D.L.; Miert, P.P.M.C. van; Anholts, J.D.H.; Fijter, H.W. de; Brand, A. & Claas, F.H.J. (2010), Differential Effect of Pretransplant Blood Transfusions on Immune Effector and Regulatory Compartments in HLA-Sensitized and Nonsensitized Recipients, Transplantation 90(11): 1192-1199.
- Wisgerhof, H.C.; Edelbroek, J.R.J.; Fijter, J.W. de; Feltkamp, M.C.W.; Willemze, R. & Bavinck, J.N.B. (2010), Trends of skin diseases in organ-transplant recipients transplanted between 1966 and 2006: a cohort study with follow-up between 1994 and 2006, British Journal of Dermatology 162(2): 390-396.
- Rossum, H.H. van; Press, R.R.; Hartigh, J. den & Fijter, J.W. de (2010), POINT - A Call for Advanced Pharmacokinetic and Pharmacodynamic Monitoring to Guide Calcineurin Inhibitor Dosing in Renal Transplant Recipients, Clinical Chemistry 56(5): 732-735.
- Rossum, H.H. van; Fijter, J.W. de & Pelt, J. van (2010), Pharmacodynamic Monitoring of Calcineurin Inhibition Therapy: Principles, Performance, and Perspectives, Therapeutic Drug Monitoring 32(1): 3-10.
- Moes, D.J.A.R.; Press, R.R.; Fijter, J.W. de; Guchelaar, H.J. & Hartigh, J. den (2010), Liquid Chromatography-Tandem Mass Spectrometry Outperforms Fluorescence Polarization Immunoassay in Monitoring Everolimus Therapy in Renal Transplantation, Therapeutic Drug Monitoring 32(4): 413-419.
- Press, R.R.; Ploeger, B.A.; Hartigh, J. den; Straaten, T. van der; Pelt, H. van; Danhof, M.; Fijter, H. de & Guchelaar, H.J. (2010), Explaining variability in ciclosporin exposure in adult kidney transplant recipients, European Journal of Clinical Pharmacology 66(6): 579-590.
- Beek, M.T. van der; Berger, S.P.; Vossen, A.C.T.M.; Blij-de Brouwer, C.S. van der; Press, R.R.; Fijter, J.W. de; Claas, E.C.J. & Kroes, A.C.M. (2010), Preemptive versus sequential prophylactic-preemptive treatment regimens for cytomegalovirus in renal transplantation: comparison of treatment failure and antiviral resistance.
- Wisgerhof HC, van der Boog PJM, de Fijter JW, Wolterbeek R, Haasnoot GW, Claas FHJ, Willemze R & Bavinck JNB (2009), Increased Risk of Squamous-Cell Carcinoma in Simultaneous Pancreas Kidney Transplant Recipients Compared with Kidney Transplant Recipients, Journal of Investigative Dermatology 129(12): 2886-2894.
- van Schaik RHN, van Agteren M, de Fijter JW, Hartmann A, Schmidt J, Budde K, Kuypers D, Le Meur Y, van der Werf M, Mamelok R & van Gelder T (2009), UGT1A9-275T > A/-2152C > T Polymorphisms Correlate With Low MPA Exposure and Acute Rejection in MMF/Tacrolimus-Treated Kidney Transplant Patients, Clinical Pharmacology and Therapeutics 86(3): 319-327.
- Press RR, Ploeger BA, den Hartigh J, van der Straaten T, van Pelt H, Danhof M, de Fijter H & Guchelaar H (2009), OPTIMIZING CALCINEURIN INHIBITOR EXPOSURE IN KIDNEY TRANSPLANT RECIPIENTS EARLY AFTER TRANSPLANTATION, Clinical Pharmacology and Therapeutics 85: S38S38.
- de Vries DK, Lindeman JHN, Tsikas D, Roos A, de Fijter JW, Baranski AG, de Heer E, van Pelt J & Schaapherder AFM (2009), EARLY RENAL ISCHEMIA-REPERFUSION INJURY IS PREVENTED BY IL-6 RELEASE FROM THE ALLOGRAFT, Transplant International 22: 184-184.
- Campistol JM, Boletis IN, Dantal J, de Fijter JW, Hertig A, Neumayer HH, Oyen O, Pascual J, Pohanka E, Ruiz JC, Scolari MP, Stefoni S, Seron D, Sparacino V, Arns W & Chapman JR (2009), Chronic allograft nephropathy - a clinical syndrome: early detection and the potential role of proliferation signal inhibitors, Clinical Transplantation 23(6): 769-777.
- Press RR, van Rossum HH, Ploeger BA, den Hartigh J, van Pelt J, Guchelaar HJ, de Fijter JW & Danhof M (2009), Is Calcineurin Activity Useful as a Biomarker to Optimize Cyclosporine a Therapy in Renal Transplant Recipients?, Therapeutic Drug Monitoring 31(5): 620-620.
- Bemelman FJ, de Maar EF, Press RR, van Kan HJ, ten Berge IJ, van der Heide JJH & de Fijter HW (2009), Minimization of Maintenance Immunosuppression Early After Renal Transplantation: An Interim Analysis, Transplantation 88(3): 421-428.
- Press RR, Ploeger BA, den Hartigh J, van der Straaten T, van Pelt J, Danhof M, de Fijter JW & Guchelaar HJ (2009), Explaining Variability in Tacrolimus Pharmacokinetics to Optimize Early Exposure in Adult Kidney Transplant Recipients, Therapeutic Drug Monitoring 31(2): 187-197.
- van Bergen J, Thompson A, Haasnoot GW, Roodnat JI, de Fijter JW, Claas FHJ, Koning F & Doxiadis II (2009), COMBINED KIR/HLA GENOTYPING INDICATES A ROLE FOR ALLOREACTIVE NATURAL KILLER CELLS IN KIDNEY TRANSPLANTATION, Transplant International 22: 354-354.
- Rekers, N.V.; Bajema, I.M.; Zuidwijk, K.; Mallat, M.J.; Goemaere, N.; Groningen, M.C. van; Kooten, C. van; Fijter, H.W. de; Claas, F.H. & Eikmans, M. (2009), Intragraft expression profiles by quantitative PCR in kidney transplant patients reflect variability in the response to anti-rejection treatment with corticosteroids, Tissue Antigens 73(5): 389-389.
- Aalten J, Bemelman FJ, van den Berg-Loonen EM, Claas FH, Christiaans MH, de Fijter JW, Hepkema BG, Hene RJ, van der Heide JJH, van Hooff JP, Lardy NM, Lems SP, Otten HG, Weimar W, Allebes WA & Hoitsma AJ (2009), Pre-kidney-transplant blood transfusions do not improve transplantation outcome: a Dutch national study, Nephrology Dialysis Transplantation 24(8): 2559-2566.
- van Schaik RHN, van Agteren M, de Fijter JW, Hartman A, Schmidt J, Budde K, Kuypers D, Le Meur Y, van der Werf M, Mamelok R & van Gelder T (2009), UGT1A9 Promoter Polymorphisms are Associated with Low MPA AUC and with Acute Rejection in MMF/tacrolimus Treated Kidney Transplant Patients, Therapeutic Drug Monitoring 31(5): 662-663.
- de Fijter JW (2009), An old virtue to improve senior programs, Transplant International 22(3): 259-268.
- Wisgerhof HC, Hameetman L, Tensen CP, Morreau H, de Fijter JW, Bavinck JNB, Willemze R & de Gruijl FR (2009), Azathioprine-Induced Microsatellite Instability Is Not Observed in Skin Carcinomas of Organ Transplant Recipients, Journal of Investigative Dermatology 129(5): 1307-1309.
- van Gelder T, Domke I, Engelmayer J, de Fijter H, Kuypers D, Budde K, Koeger R, Luthe H & Oellerich M (2009), Clinical Utility of a New Enzymatic Assay for Determination of Mycophenolic Acid in Comparison With an Optimized LC-MS/MS Method, Therapeutic Drug Monitoring 31(2): 218-223.
- Zuidwijk K, de Fijter JW, Mallat MJK, Eikmans M, Bajema I & van Kooten C (2009), Increased Numbers of Myeloid and Plasmacytoid Dendritic Cells during Human Renal Allograft Rejection Are Accompanied by Local Maturation., American Journal of Transplantation 9: 554-554.
- de Vries DK, Lindeman JHN, Tsikas D, de Heer E, Roos A, de Fijter JW, Baranski AG, van Pelt J & Schaapherder AFM (2009), Early Renal Ischemia-Reperfusion Injury in Humans Is Dominated by IL-6 Release from the Allograft, American Journal of Transplantation 9(7): 1574-1584.
- Eikmans M, Nacken W, Bajema IM, Zuidwijk K, Roos-van Groningen MC, van Kooten C, de Fijter JW, Bruijn JA, Roth J & Claas FHJ (2008), Presence of macrophage-expressed S100 calcium binding proteins AS and A9 during transplant rejection is associated with expression of IL-4, IL-10, and TGF-beta, Tissue Antigens 71(4).
- Wisgerhoi HC, de Fijter JW, Claas FH, Willemze R & Bavinck JNB (2008), Immunosuppression with rnycofenolatemofetil in stead of azathioprine significantly reduces the risk of skin cancer in kidney transplant recipients, Journal of Investigative Dermatology 128.
- Verschuren JJW, Roos A, Schaapherder AFM, Mallat MJK, Daha MR, de Fijter JW & Berger SP (2008), Infectious complications after simultaneous pancreas-kidney transplantation: A role for the lectin pathway of complement activation, Transplantation 85(1).
- Hesselink DA, van Schaik RHN, van Agteren M, de Fijter JW, Hartmann A, Zeier M, Budde K, Kuypers DRJ, Pisarski P, Le Meur Y, Mamelok RD & van Gelder T (2008), CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients, Pharmacogenetics and Genomics 18(4).
- Mourer JS, de Koning EJP, Berger SP, Roodt JO, Spaans M, Rabelink AJ & de Fijter JW (2008), Effects of CNI or MMF withdrawal on carotid intima media thickness in renal transplant recipients, American Journal of Transplantation 8.
- van Rossum HH, Romijn FPHTM, Sellar KJ, Smit NPM, van der Boog PJM, de Fijter JW & van Pelt J (2008), Variation in leukocyte subset concentrations affects calcineurin activity measurement: Implications for pharmacodynamic monitoring strategies, Clinical Chemistry 54(3).
- Eikmans M, Roelen DL, van Kooten C, de Fijter HW & Claas FHJ (2008), Increased mRNA expression of transforming growth factor-beta and FoxP3 in urine from renal allograft recipients is associated with occurrence of graft rejection, American Journal of Transplantation 8.
- Eijgenraam JW, Oortwijn BD, Kamerling SWA, de Fijter JW, Bake AWLV, Daha MR & van Kooten C (2008), Secretory immunoglobulin A (IgA) responses in IgA nephropathy patients after mucosal immunization, as part of a polymeric IgA response, Clinical and Experimental Immunology 152(2).
- van Es LA, de Heer E, Vleming LJ, van der Wal A, Mallat M, Bajema I, Bruijn JA & de Fijter JW (2008), GMP-17-positive T-lymphocytes in renal tubules predict progression in early stages of IgA nephropathy, Kidney International 73(12).
- Waanders MM, Roelen DL, de Fijter JW, Mallat MJK, Ringers J, Doxiadis IIN, Brand A & Claas FHJ (2008), Protocolled blood transfusions in recipients of a simultaneous pancreas-kidney transplant reduce severe acute graft rejection, Transplantation 85(11).
- van Agteren M, Armstrong VW, van Schaik RHN, de Fijter H, Hartmann A, Zeier M, Budde K, Kuypers D, Pisarski P, Le Meur Y, van der Werf M, Mamelok RD, Oellerich M & van Gelder T (2008), AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G > A gene polymorphism, Therapeutic Drug Monitoring 30(4).
- Aalten J, Hoogeveen EK, Roodnat JI, Weimar W, Borm GF, de Fijter JW & Hoitsma AJ (2008), Associations between pre-kidney-transplant risk factors and post-transplant cardiovascular events and death, Transplant International 21(10).
- Wisgerhof HC, de Fijter JW, Claas FHJ, Willemze R & Bavinck JNB (2008), Patients with an increased number of kidney grafts have a decreased risk to develop squamous-cell carcinoma after transplantation, Journal of Investigative Dermatology 128(10).
- Lard LR, van der Boog PJM, Veselic M, Vossen ACTM, de Fijter JW & Groeneveld JHM (2008), A pitfall in screening with decoy cells after simultaneous pancreas kidney transplantation, Clinical Transplantation 22(6).
- van Gelder T, Silva HT, de Fijter JW, Budde K, Kuypers D, Tyden G, Lohmus A, Sommerer C, Hartmann A, Le Meur Y, Oellerich M, Holt DW, Tonshoff B, Keown P, Campbell S & Mamelok RD (2008), Comparing Mycophenolate Mofetil Regimens for de Novo Renal Transplant Recipients: The Fixed-Dose Concentration-Controlled Trial, Transplantation 86(8).
- van Kan HJM, Issa T, Rowshani AT, Press RR & de Fijter JW (2008), Comparison of limited sampling strategies of immunosuppressive therapy in adult renal transplant recipients, British Journal of Clinical Pharmacology 66(5).
- Woltman AM, de Fijter JW, Zuidwijk K, Vlug AG, Bajema IM, van der Kooij SW, van Ham V & van Kooten C (2007), Quantification of dendritic cell subsets in human renal tissue under normal and pathological conditions, Kidney International 71(10).
- Doxiadis IIN, de Fijter JW, Mallat MJK, Haasnoot GW, Ringers J, Persijn GG & Claas FHJ (2007), Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility, Transplantation 83(9).
- Berger SP, Verschuren JJW, Mallat MJK, Daha MR, De Fijter JW & Roos A (2007), Infectious complications after simultaneous pancreas-kidney transplantation: A role for the lectin pathway of complement activation?, American Journal of Transplantation 7.
- Press RR, Ploeger BA, den Hartigh J, van der Straaten RJHM, van Pelt J, Danhof M, de Fijter JW & Guchelaar HJ (2007), Improved dose prediction of tacrolimusin de novo kidney transplant patients with population pharmacokinetic modelling including genetic polymorphismis., American Journal of Transplantation 7.
- Berger SP, Roos A, Mallat MJK, Schaapherder AF, Doxiadis II, van Kooten C, Daha MR & de Fijter JW (2007), Low mannose-binding lectin levels are associated with superior graft and patient survival after simultaneous pancreas-kidney transplantation., American Journal of Transplantation 7.
- Berger SP, Roos A, Mallat MJK, Schaapherder AFM, Doxiadis II, van Kooten C, Dekker FW, Daha MR & de Fijter JW (2007), Low pretransplantation mannose-binding lectin levels predict superior patient and graft survival after simultaneous pancreas-kidney transplantation, Journal of the American Society of Nephrology 18(8).
- De Fijter JW, Mourer JS, Den Hartigh J, Mallat MJ & Berger SP (2007), Concentration-controlled systemic exposure provides improved safety after CNI or MMF withdrawal., American Journal of Transplantation 7.
- Waanders MM, Roelen DL, de Fijter JW, Mallat MJ, Doxiadis IIN, Brand A & Claas FHJ (2007), The effect of pretransplant blood transfusions in recipients of a simultaneous pancreas-kidney transplant, Tissue Antigens 69(5).
- Roukens, A.H.E.; Dissel, J.T. van; Fijter, J.W. de & Visser, L.G. (2007), Health preparations and travel-related morbidity of kidney transplant recipients traveling to developing countries, Clinical Transplantation 21(4).
- Press RR, Ploeger BA, den Hartigh J, van der Straaten RJHM, van Pelt J, Danhof M, de Fijter JW & Guchelaar HJ (2007), Dose prediction of tacrolimus in de novo kidney transplant patients with population pharmacokinetic modelling including genetic polymorphisms, Therapeutic Drug Monitoring 29(4).
- Press RR, Ploeger BA, den Hartigh J, Bemelman FJ, van der Heides JJH, Danhof M, Guchelaar HJ & de Fijter JW (2007), TDM of everolimus in stable renal transplant patients after CNI withdrawal, Therapeutic Drug Monitoring 29(4).
- Berger SP, Roos A, Mallat MJK, de Fijter JW & Daha MR (2007), Pre-transplantation MBL levels predict patient and graft survival after simultaneous pancreas - kidney transplantation, Molecular Immunology 44(1-3).
- Stokkel M, Duchateau CS, Jukema W & de Fijter HW (2007), Noninvasive assessment of left ventricular function prior to and 6 months after renal transplantation, Transplantation Proceedings 39(10).
- van de Linde P, van der Boog PJM, Tysma OMH, Elliott JF, Roelen DL, Claas FHJ, de Fijter JW & Roep BO (2007), Selective unresponsiveness to beta cell autoantigens after induction immunosuppression in pancreas transplantation with anti-interleukin-2 receptor antibody versus anti-thymocyte globulin, Clinical and Experimental Immunology 149(1).
- Heller T, van Gelder T, Budde K, de Fijter JW, Kuypers D, Arns W, Schmidt J, Rostaing L, Powis SH, Claesson K, MacPhee IAM, Pohanka E, Engelmayer J, Brandhorst G, Oellerich M & Armstrong VW (2007), Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipients, American Journal of Transplantation 7(7).
- Aydin Z, van Zonneveld AJ, de Fijter JW & Rabelink TJ (2007), New horizons in prevention and treatment of ischaemic injury to kidney transplants, Nephrology Dialysis Transplantation 22(2).
- Campistol JM, Albanell J, Arns W, Boletis I, Dantal J, de Fijter JW, Mortensen SA, Neumayer HH, Oyen O, Pascual J, Pohanka E, Schena FP, Seron D, Sparacino V & Chapman JR (2007), Use of proliferation signal inhibitors in the management of post-transplant malignancies - clinical guidance, Nephrology Dialysis Transplantation 22.
- de Fijter JW (2007), Use of proliferation signal inhibitors in non-melanoma skin cancer following renal transplantation, Nephrology Dialysis Transplantation 22.
- van Rossum HH, Romijn FP, Lentz-Ljuboje R, de Fijter JW & van Pelt H (2007), Monitoring of calcineurin activity under controlled systemic CNI exposure after kidney transplantation., Clinical Chemistry 53(6).
- Oortwijn BD, van der Boog PJM, Roos A, van der Geest RN, de Fijter JW, Daha MR & van Kooten C (2006), A pathogenic role for secretory IgA in IgA nephropathy, Kidney International 69(7).
- Scholten EM, Rowshani AT, Cremers S, Bemelman FJ, Eikmans M, van Kan E, Mallat MJ, Florquin S, Surachno J, ten Berge IJ, Bajema IM & de Fijter JW (2006), Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function, Journal of the American Society of Nephrology 17(9).
- Woltman AM, van der Kooij SW, de Fijter JW & van Kooten C (2006), Maturation-resistant dendritic cells induce hyporesponsiveness in alloreactive CD45RA(+) and CD45RO(+) T-cell populations, American Journal of Transplantation 6(11).
- Arend SM, Kuijper EJ, de Vaal BJ, de Fijter JW & van't Wout JW (2006), Successful treatment of fungus balls due to fluconazole-resistant Candida sake obstructing ureter stents in a renal transplant patient, European Journal of Clinical Microbiology and Infectious Diseases 25(1).
- van den Boogaardt DEM, van Miert PPMC, de Vaal YJH, de Fijter JW, Claas FHJ & Roelen DL (2006), The ratio of interferon-gamma and interleukin-10 producing donor-specific cells as an in vitro monitoring tool for renal transplant patients, Transplantation 82(6).
- Rowshani AT, Scholten EM, Bemelman F, Eikmans M, Idu M, van Groningen MCR, Surachno JS, Mallat MJK, Paul LC, de Fijter JW, Bajema IM, ten Berge I & Florquin S (2006), No difference in degree of interstitial sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year, Journal of the American Society of Nephrology 17(1).
- Huurman VAL, Kalpoe JS, Van de Linde P, Vaessen N, Ringers J, Kroes ACM, Roep BO & De Fijter JW (2006), Choice of antibody immunotherapy influences cytomegalovirus viremia in simultaneous pancreas-kidney transplant recipients, Diabetes Care 29(4).
- Groningen MCRV, Scholten EM, Lelieveld PM, Rowshani AT, Baelde HJ, Bajema IM, Florquin S, Bemelman FJ, de Heer E, de Fijter JW, Bruijn JA & Eikmans M (2006), Molecular comparison of calcineurin inhibitor-induced fibrogenic responses in protocol renal transplant biopsies, Journal of the American Society of Nephrology 17(3).
- Sellar KJ, van Rossum HH, Romijn FPHTM, Smit NPM, de Fijter JW & van Pelt J (2006), Spectrophotometric assay for calcineurin activity in leukocytes isolated from human blood, Analytical Biochemistry 358(1).
- Eikmans M, Roos-van Groningen MC, Sijpkens YWJ, Ehrchen J, Roth J, Baelde HJ, Bajema IM, de Fijter JW, de Heer E & Bruijn JA (2005), Expression of surfactant protein-C, S100A8, S100A9, and B cell markers in renal allografts: Investigation of the prognostic value, Journal of the American Society of Nephrology 16(12).
- Woltman AM, de Fijter JW, van der Kooij SW, Jie KE, Massacrier C, Caux C, Daha MR & van Kooten C (2005), MIP-3 alpha/CCL20 in renal transplantation and its possible involvement as dendritic cell chemoattractant in allograft rejection, American Journal of Transplantation 5(9).
- Berger SP, Roos A, Mallat MJK, Fujita T, de Fijter JW & Daha MR (2005), Association between mannose-binding lectin levels and graft survival in kidney transplantation, American Journal of Transplantation 5(6).
- Cremers S, Schoemaker R, Scholten E, den Hartigh J, Konig-Quartel J, van Kan E, Paul L & de Fijter J (2005), Characterizing the role of enterohepatic recycling in the interactions between mycophenolate mofetil and calcineurin inhibitors in renal transplant patients by pharmacokinetic modelling, British Journal of Clinical Pharmacology 60(3).
- Eijgenraam JW, Woltman AM, Kamerling SWA, Briere F, de Fijter JW, Daha MR & van Kooten C (2005), Dendritic cells of IgA nephropathy patients have an impaired capacity to induce IgA production in naive B cells, Kidney International 68(4).
- Kalpoe JS, Schippers EF, Eling Y, Sijpkens YW, de Fijter JW & Kroes ACM (2005), Similar reduction of cytomegalovirus DNA load by oral valganciclovir and intravenous ganciclovir on pre-emptive therapy after renal and renal-pancreas transplantation, Antiviral Therapy 10(1).
- Scholten EM, Cremers SCLM, Schoemaker RC, Rowshani AT, van Kan EJ, den Hartigh J, Paul LC & de Fijter JW (2005), AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients, Kidney International 67(6).
- Boom H, deHeer H, van der Wal A, Kruidenier L, de Fijter JW, Benediktsson H, Paul LC & van Es LA (2005), The absence of delayed graft function is predicted by the presence of manganese-superoxide dismutase in distal tubules of renal allografts, Transplantation 79(8).
- de Fijter JW (2005), The impact of age on rejection in kidney transplantation, Drugs and Aging 22(5).
- de Fijter JW & Persijn GG (2005), Age, the riddle of renal transplantation, Nephrology Dialysis Transplantation 20(11).
- van den Dool SW, Wasser MN, de Fijter JW, Hoekstra J & van der Geest RJ (2005), Functional renal volume: Quantitative analysis at gadolinium-enhanced MR angiography - Feasibility study in healthy potential kidney donors, Radiology 236(1).
- Doxiadis I, de Fijter J, Haasnoot G, Mallat M, Persijn G & Claas F (2005), Identification of parameters that contribute to a successful kidney retransplantation, Human Immunology 66.
- Boom H, Mallat MJK, De Fijter JW, Paul LC, Bruijn JA & Van Es LA (2004), Calcium levels as a risk factor for delayed graft function, Transplantation 77(6).
- Joosten SA, van Kooten C, Sijpkens YWJ, de Fijter JW & Paul LC (2004), The pathobiology of chronic allograft nephropathy: Immune-mediated damage and accelerated aging, Kidney International 65(5).
- van der Boog PJM, van Kooten C, van Zandbergen G, Klar-Mohamad N, Oortwijn B, Bos NA, van Remoortere A, Hokke CH, de Fijter JW & Daha MR (2004), Injection of recombinant Fc alpha RI/CD89 in mice does not induce mesangial IgA deposition, Nephrology Dialysis Transplantation 19(11).
- Smets YFC, de Fijter JW, Ringers J, Lemkes HHPJ & Hamdy NAT (2004), Long-term follow-up study on bone mineral density and fractures after simultaneous pancreas-kidney transplantation, Kidney International 66(5).
- Paul LC & de Fijter JH (2004), Cyclosporine-induced renal dysfunction, Transplantation Proceedings 36(2).
- de Fijter JW (2004), Diabetic nephropathy and beta-cell replacement therapy, Netherlands Journal of Medicine 62(3).
- Sijpkens YWJ, Doxiadis IIN, van Kemenade FJ, Zwinderman AH, de Fijter JW, Claas FHJ, Bruijn JA & Paul LC (2003), Chronic rejection with or without transplant vasculopathy, Clinical Transplantation 17(3).
- Ilias D, de Fijter J, Mallat M, de Lange P, Paul L & Claas F (2003), HLA matching in cadaveric renal transplantation revisited: Major impact of the full HLA-DR compatibility allowing simpler and equitable allocation of organs., Genes and Immunity 4.
- Cremers SCLM, Scholten EM, Schoemaker RC, Lentjes EGWM, Vermeij P, Paul LC, den Hartigh J & de Fijter JW (2003), A compartmental pharmacokinetic model of cyclosporin and its predictive performance after Bayesian estimation in kidney and simultaneous pancreas-kidney transplant recipients, Nephrology Dialysis Transplantation 18(6).
- Bakker RC, Hollander AAMJ, Mallat MJK, Bruijn JA, Paul LC & de Fijter JW (2003), Conversion from cyclosporine to azathioprine at three months reduces the incidence of chronic allograft nephropathy, Kidney International 64(3).
- van der Boog PJM, de Fijter JW, van Kooten C, van der Holst R, van Seggelen A, van Es LA & Daha MR (2003), Complexes of IgA with Fc alpha RI/CD89 are not specific for primary IgA nephropathy, Kidney International 63(2).
- Termorshuizen F, Hogewoning AA, Bavinck JNB, Goettsch WG, Fijter JW & Loveren H (2003), Skin infections in renal transplant recipients and the relation with solar ultraviolet radiation, Clinical Transplantation 17(6).
- Sijpkens YWJ, Doxiadis IIN, Mallat MJK, De Fijter JW, Bruijn JA, Claas FHJ & Paul LC (2003), Early versus late acute rejection episodes in renal transplantation, Transplantation 75(2).
- Jukema JW, Smets YFC, van der Pijl JW, Zwinderman AH, Vliegen HW, Ringers J, Reiber JHC, Lemkes HHPJ, van der Wall EE & de Fijter JW (2002), Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end-stage renal failure due to type 1 diabetes, Diabetes Care 25(5).
- El-Maghraby TAF, Boom H, Camps JAJ, Blokland KAK, Zwinderman AH, Paul LC, Pauwels EKJ & de Fijter JW (2002), Delayed graft function is characterized by reduced functional mass measured by (99m)technetium-mercaptoacetyltriglycine renography, Transplantation 74(2).
- Woltman AM, Massacrier C, de Fijter JW, Caux C & van Kooten C (2002), Corticosteroids prevent generation of CD34(+)-derived dermal dendritic cells but do not inhibit langerhans cell development, Journal of Immunology 168(12).
- Schnuelle P, Van der Heide JH, Tegzess A, Verburgh CA, Paul LC, Van der Woude FJ & De Fijter JW (2002), Open randomized trial comparing early withdrawal of either cyclosporine or mycophenolate mofetil in stable renal transplant recipients initially treated with a triple drug regimen, Journal of the American Society of Nephrology 13(2).
- Boom H, Mallat MJK, de Fijter JW, Zwinderman AH & Paul LC (2001), Delayed graft function influences renal function but not survival, Transplantation Proceedings 33(1-2).
- Straathof-Galema L, van Saase JLCM, Verburgh CA, de Fijter JW, Schut NH & van Dorp WT (2001), Morbidity and mortality during renal replacement therapy: dialysis versus transplantation, Clinical Nephrology 55(3).
- Sijpkens YWJ, Mallat MJK, Siegert CEH, Zwinderman AH, Westendorp RGJ, de Fijter JW, van Es LA & Paul LC (2001), Risk factors of cyclosporine nephrotoxicity after conversion from Sandimmune to Neoral, Clinical Nephrology 55(2).
- Hogewoning AA, Goettsch W, van Loveren H, de Fijter JW, Vermeer BJ & Bavinck JNB (2001), Skin infections in renal transplant recipients, Clinical Transplantation 15(1).
- Schaar CG, van der Pijl JW, van Hoek B, de Fijter JW, Veenendaal RA, Kluin PM, van Krieken JHJ, Hekman A, Terpstra WE, Willemze R & Kluin-Nelemans HC (2001), Successful outcome with a "quintuple approach" of posttransplant lymphoproliferative disorder, Transplantation 71(1).
- Woltman AM, de Fijter JW, Kamerling SWA, van der Kooij SW, Paul LC, Daha MR & van Kooten C (2001), Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages, Blood 98(1).
- De Fijter JW, Mallat MJK, Doxiadis IIN, Ringers J, Rosendaal FR, Claas FHJ & Paul LC (2001), Increased immunogenicity and cause of graft loss of old donor kidneys, Journal of the American Society of Nephrology 12(7).
- Smets YFC, Van der Pijl JW, Frolich M, Ringers J, De Fijter JW & Lemkes MHPJ (2000), Insulin secretion and sensitivity after simultaneous pancreas-kidney transplantation estimated by continuous infusion of glucose with model assessment.
- Woltman AM, de Fijter JW, Kamerling SWA, Paul LC, Daha MR & van Kooten C (2000), The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells.
- Boom H, Mallat MJK, De Fijter JW, Zwinderman AH & Paul LC (2000), Delayed graft function influences renal function, but not survival.
- de Jong-Tieben LM, Berkhout RJM, ter Schegget J, Vermeer BJ, de Fijter JW, Bruijn JA, Westendorp RGJ & Bavinck JNB (2000), The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: A clinical study to assess risk factors for keratotic skin lesions and skin cancer.
- Van Riemsdijk IC, Mulder PG, De Fijter JW, Bruijn JA, Van Hooff JP, Hoitsma AJ, Tegzess AM & Weimar W (2000), Addition of isradipine (Lomir) results in a better renal function after kidney transplantation: A double-blind, randomized, placebo-controlled, multicenter study.
- van der Bijl AE, Kamper AM, de Fijter JW & Paul LC (2000), Mycoplasma hominis peritonitis after renal transplantation, Nephron 86(4).
- Regionaal Tuchtcollege voor de Gezondheidszorg
- lid Concilium Interne Geneeskunde
- Voorzitter Commissie Behoefteraming en Capaciteitsplanning